bims-ribost Biomed News
on Ribostasis and translation stress
Issue of 2026–11–01
eighty-six papers selected by
Cédric Chaveroux, CNRS



  1. Semin Hematol. 2026 Oct 03. pii: S0037-1963(26)00091-0. [Epub ahead of print]
      Ribosomes are essential ribonucleoprotein complexes that translate genetic information into proteins and are therefore central to cellular growth, development, and homeostasis. Recent advances in structural biology and genomics have transformed our understanding of ribosomes from static translational machines to highly dynamic complexes whose assembly, function, and quality control are tightly regulated. In this review, we provide an overview of eukaryotic ribosome structure and biogenesis, focusing on insights gained from yeast and human systems. We discuss the hierarchical assembly of ribosomal subunits, rRNA processing and modification, nuclear export, and cytoplasmic maturation. Particular emphasis is placed on the surveillance mechanisms that monitor ribosome assembly, including structural proofreading, molecular mimicry, RNA decay pathways, and translation-like "test-drive" reactions that assess ribosome competence. We further examine how defects in ribosome biogenesis and translation activate nucleolar surveillance, ribosome quality-control pathways, and downstream stress-response networks, including p53 signaling, the integrated stress response, and ribotoxic stress pathways. Together, these mechanisms form an interconnected quality-control system that safeguards ribosome function and cellular protein homeostasis. These studies provide important insights into the molecular basis of numerous ribosomal diseases and related disorders associated with defective ribosome biogenesis and function. Finally, we highlight emerging questions regarding ribosome heterogeneity, specialization, and the relationship between ribosome quality control and human disease.
    Keywords:  Quality control; Ribosome; Ribosome assembly; Ribotoxic stress
    DOI:  https://doi.org/10.1053/j.seminhematol.2026.09.011
  2. J Cell Sci. 2026 Oct 15. pii: jcs264886. [Epub ahead of print]139(20):
      GCN2 (also known as EIF2AK4) is a conserved serine/threonine kinase best known for linking amino acid availability to activation of the integrated stress response (ISR) through phosphorylation of eukaryotic translation initiation factor 2α (eIF2α). This canonical activity promotes adaptive translational and transcriptional programmes that support metabolic homeostasis and stress tolerance, which has motivated efforts to therapeutically target GCN2, particularly in cancer. Recent work, however, indicates that this framework captures only a subset of GCN2 biology. GCN2 has been shown to engage additional substrates beyond eIF2α, including the methionyl-tRNA synthetase (MARS1) and the catalytic subunits of protein phosphatase-1 (PP1), and has been implicated in a growing range of cellular processes, such as mitotic fidelity, cell migration and ribosome homeostasis. Together, these findings establish GCN2 as a multifunctional kinase whose cellular roles cannot be inferred solely from canonical ISR readouts. Here, we synthesize emerging evidence for noncanonical GCN2 activities and consider how this expanded view shapes interpretation of genetic and pharmacological perturbations and the development of therapeutic strategies targeting GCN2.
    Keywords:  GCN2; ISR; Migration; Mitosis; Non-canonical; Ribosome homeostasis
    DOI:  https://doi.org/10.1242/jcs.264886
  3. Methods Mol Biol. 2027 ;3101 89-103
      Translation of mRNA into full-length protein is a relatively short-lived and dynamic process. Many classical biochemical techniques lack the resolution required to capture both spatial and temporal information of ribosome activity-initiation, elongation, and termination. This limitation is exacerbated in a live cell context. Recent advances in plasmid expression vectors, epitope tags, and fluorescent proteins now allow for quantitative and stream-lined imaging of single-mRNA translation in living cells. This protocol describes the use of "All Probes Plasmids" to lower the barrier for imaging and quantifying single-mRNA translation events in living cells.
    Keywords:  Fluorescence microscopy; Live-cell imaging; Ribosomal dynamics; Single-molecule; mRNA translation
    DOI:  https://doi.org/10.1007/978-1-0716-5687-7_5
  4. Front Immunol. 2026 ;17 1952952
      RNA methylation serves as an essential post-transcriptional epigenetic modification for gene expression regulation. The methyltransferase-like (METTL) family is characterized by conserved methyltransferase domains. These members can recognize multiple RNA substrates including messenger RNA (mRNA), ribosomal RNA (rRNA), and mitochondrial RNA (mtRNA), and engage in a variety of RNA methylation processes. They exhibit markedly heterogeneous tumor-regulatory functions. The METTL3/14 complex regulates tumor proliferation, metastasis, metabolic reprogramming and immunotherapy resistance by catalyzing mRNA N6-methyladenosine (m6A) modification. METTL5 targets rRNA and drives translational reprogramming to participate in tumor progression and T cell immune resistance. METTL17 mediates multiple methylations of mtRNA to deregulate mitochondrial metabolism and drive malignant tumor phenotypes. METTL16 possesses both mRNA m6A catalytic and small nuclear RNA non-catalytic functions, and participates in tumor progression and immune escape. METTL4 catalyzes N6, 2'-O-dimethyladenosine methylation to modulate target gene translation and facilitate tumorigenesis. Beyond RNA methylation, METTL7A/B promotes resistance to tumor-targeted drugs via m6A-independent mechanisms of DNA binding and protein interactions. Notably, the same METTL protein yields distinct immunoregulatory effects in tumor cells, T cells, macrophages and natural killer cells, with obvious context-dependence. In this paper, we systematically summarize structural features and functions of METTL family proteins, together with mechanisms underlying their regulation of the tumor immune microenvironment. We also consolidate the research progress and transformation bottlenecks of multiple targeted candidate molecules. It provides a theoretical basis and new ideas for further investigations of METTL-based tumor immunotargeted therapy.
    Keywords:  METTL family; METTL inhibitor; antitumor; immune response; m6A modification; methyltransferase
    DOI:  https://doi.org/10.3389/fimmu.2026.1952952
  5. Int J Mol Sci. 2026 Oct 17. pii: 9234. [Epub ahead of print]27(20):
      Cancer cells hijack RNA metabolism, including splicing, polyadenylation, nuclear export and translation, to change both the amount and the form of the proteins they produce. This creates therapeutic vulnerabilities beyond the mutations and translocations that have guided drug development in acute myeloid leukemia (AML), where outcomes remain poor. Using AML as a paradigm, this review focuses on two nodes of RNA metabolism: the eukaryotic translation initiation factor eIF4E, a cap-chaperone that escorts mRNAs through processing, export and translation, and CRM1/XPO1, the major nuclear exporter of proteins and select RNAs that partners with eIF4E for specific mRNA export activity. We describe the RNA biology dysregulated in patients, the mechanisms of the inhibitors that target these pathways, and their pre-clinical and clinical data across AML and other malignancies. Indeed, early-stage clinical trials in AML and other malignancies show promise, including the use of CRM1/XPO1 inhibitors (selinexor, eltanexor) and eIF4E inhibitors (including ribavirin and tomivosertib). We discuss how selecting patients by eIF4E status, confirming on-target activity, and designing rational combinations could improve next-generation therapies.
    Keywords:  CRM1/XPO1; clinical trials; eIF4E; mRNA export; mRNA translation
    DOI:  https://doi.org/10.3390/ijms27209234
  6. RNA Biol. 2026 Dec;23(1): 1-17
      A cardinal factor in the regulation of mRNA life and function is the cap-binding protein eIF4E. eIF4E promotes the recruitment of mRNA to the ribosome during the initiation step of translation, but other activities have been described, including mRNA processing, export, and storage. To perform these functions, eIF4E must associate with the mRNA cap and a number of different eIF4E-interacting proteins (4E-IPs). Thus, eIF4E has evolved as a key interface between RNA metabolism, gene expression, and development. In Drosophila melanogaster, seven genes encode eight eIF4E cognate proteins that have functionally diverged to perform different activities. We review the structure, interactors, biochemistry, and activities of the Drosophila eIF4E paralogs, which represent a paradigm of divergence during metazoan development.
    Keywords:  Translation initiation; development; drosophila; eIF4E; translational control
    DOI:  https://doi.org/10.1080/15476286.2026.2753988
  7. Nucleic Acids Res. 2026 Oct 24. pii: gkag1019. [Epub ahead of print]54(20):
      RNA structures that form inside living cells govern processes ranging from translation to RNA decay, many of which are controlled by RNA-binding proteins (RBPs). Because RBP specificity can depend on both RNA sequence and folding, traditional pulldown-based methods often obscure the structural context of bound RNAs. Here, a quantitative framework based on dimethyl sulfate mutational profiling and sequencing was established to directly measure RNA structure and RBP binding in human cells at single-nucleotide resolution. Applied to a 1600-member MS2 hairpin library, this approach revealed that RNA folding is the strongest determinant of MS2 coat protein (MCP) recognition in the MS2-MCP system, requiring formation of a stable hairpin and a consensus loop sequence, with stem length or GC content contributing primarily through their effect on hairpin folding. An in-cell occupancy model was derived to quantify fractional binding from structural readouts. Complementary systems using degron-tuned MCP and a downregulatory MCP fusion demonstrated binding behavior under subsaturating protein concentrations and showed that inferred occupancy quantitatively predicts RNA degradation efficiency. Together, these results establish a quantitative strategy for measuring RBP-RNA specificity and affinity directly in cells, using the MS2-MCP system to link RNA structure, protein occupancy, and regulatory outcome.
    DOI:  https://doi.org/10.1093/nar/gkag1019
  8. Autophagy. 2026 Oct 27. 1-15
      The condition of having a healthy, functional proteome is known as protein homeostasis, or proteostasis. Maintaining proteostasis is the province of the proteostasis network, which consists of the cellular components that regulate protein synthesis, folding, localization, and degradation. The proteostasis network is a fundamental functional unit in biology with relevance to many diseases. Despite its importance, the human proteostasis network has until now lacked a precise definition, limiting our ability to interrogate proteostasis, integrate multiomic datasets, compare results across studies, or model proteostasis dysfunction in disease. To address this limitation, we have operationally defined the human proteostasis network by providing a comprehensive, annotated, and manually curated list of its components classified into nine Branches based on their function and localization - cytonuclear proteostasis, ER proteostasis, mitochondrial proteostasis, nuclear proteostasis, proteostasis network regulation, translation, extracellular proteostasis, the autophagy-lysosome pathway, and the ubiquitin-proteasome system - which we present in a series of three manuscripts of which this is the first. Overall, the proteostasis network annotation encompasses 3,151 components described by 4,043 annotations. Here, we present the 1,190 components that make up the first seven of these Branches, which comprise the compartment-based proteostasis network (cytonuclear, ER, mitochondrial, nuclear, and extracellular proteostasis), proteostasis network regulation, and translation. These Branches include chaperones, folding enzymes, systems for trafficking proteins, organelle-specific degradation systems, and the cell's translation machinery. This work provides a framework that will facilitate insights into how proteostasis is preserved in health, lost in aging and disease, and how it could be restored through pharmacological intervention.
    Keywords:  Annotation; cellular stress responses; chaperones; protein folding; protein synthesis; protein transport
    DOI:  https://doi.org/10.1080/15548627.2026.2741033
  9. bioRxiv. 2026 Sep 01. pii: 2026.08.31.748072. [Epub ahead of print]
      RNA viruses often enhance ribosome recruitment to their own mRNAs through non-canonical sequence elements or by degrading host mRNA. Respiratory syncytial virus (RSV) produces mRNAs with host-like features, including 5'-cap and poly(A) tail. Therefore, the virus lacks an obvious mechanism to preferentially protect its own mRNAs or recruit ribosomes. Furthermore, it remains unknown how RSV interacts with antiviral defense pathways that would reduce cap-dependent translation. Using spike-in normalized sequencing of total and ribosome-associated RNA, we found that RSV does not appear to evoke any host shutoff mechanisms to limit the expression of host genes. These findings show that RSV manages to make use of available ribosomes by competing effectively with host mRNAs and any translational shutoff mechanism would be detrimental. Consistent with this, we found that following activation of antiviral host pathways that reduce cap-dependent translation, translation of RSV mRNAs is decreased to the same extent as host mRNAs. Furthermore, we found that RSV infection does not trigger the dsRNA-activated kinase PKR (which initiates the ISR) and OAS (activates endonuclease RNase L) pathways. These data support a model in which RSV achieves viral protein production, not though inhibiting the host, but by successfully competing with host mRNAs and avoiding activation of antiviral pathways.
    Highlights: RSV does not induce host mRNA degradationRSV mRNAs effectively recruit ribosomes throughout infection and cause some reduction in host mRNA translationRSV mRNAs depend on eIF4E for translation and are stabilized independently of LARP1 when eIF4E is depletedRSV avoids strong activation of the ISR and OAS/RNaseL pathways instead of directly inhibiting their activation.
    DOI:  https://doi.org/10.64898/2026.08.31.748072
  10. ACS Bio Med Chem Au. 2026 Oct 21. 6(5): 651-657
      Liquid-liquid phase separation (LLPS) is a process in which proteins and nucleic acids organize into dynamic, membrane-less structures within cells. These structures help regulate cellular processes such as gene expression, molecular storage, and stress responses through weak interactions between disordered protein regions and RNA. Emerging evidence highlights a regulatory role for epitranscriptomic modifications, particularly N6-methyladenosine (m6A), though the underlying mechanisms remain unclear. Here, we investigated the relationship between m6A RNA nucleotide modification and LLPS by identifying proteins that selectively bind methylated RNA. An RNA pull-down assay enriched 106 proteins, including 53 known RNA-binding proteins and several proteins that support LLPS, including FUS (Fused in sarcoma). FUS, a well-characterized phase-separating RNA-binding protein, showed a 2-fold higher binding affinity for m6A-modified hairpin RNA than for its unmodified counterpart. Cloud-point analysis and coherent anti-Stokes Raman scattering (CARS) microscopy revealed enhanced thermodynamic stability at higher m6A levels in total RNA extracts. Quantitative CARS imaging revealed that, although the overall RNA-to-protein ratio within condensates remains largely unchanged, larger droplets under high-m6A conditions exhibit increased RNA content, suggesting that m6A strengthens RNA-protein interactions without significantly altering the stoichiometry. Collectively, these findings indicate that while protein-protein interactions may initiate LLPS, m6A-modulated RNA-protein interactions govern condensate growth and stability. Furthermore, these results provide a mechanistic insight into how epitranscriptomic modifications regulate biomolecular condensation and influence cellular organization, gene regulation, and disease processes.
    Keywords:  CARS microscopy; FUS; LLPS; m6A; post-transcriptional modifications
    DOI:  https://doi.org/10.1021/acsbiomedchemau.6c00101
  11. Int J Mol Med. 2026 Dec;pii: 348. [Epub ahead of print]58(6):
      RNA 5‑methylcytosine (m5C) regulates RNA stability, processing and translation, linking changes in nutrient supply and stress to cancer‑cell behavior. Its consequences depend on the RNA substrate and the proteins that recognize or process the modification. This dependence helps explain why NOP2/Sun RNA methyltransferase 2 (NSUN2), NOP2 nucleolar protein, NSUN5, NSUN6 and tRNA aspartic acid methyltransferase 1 can affect proliferation, metabolism, immunity and treatment response differently. Across coding and noncoding RNAs, m5C regulation can sustain growth‑related protein expression, alter DNA damage repair and support metabolic defenses against cell death. Metabolites also regulate writers and readers, creating feedback in specific tumor models that connects nutrient availability with RNA recognition. These relationships suggest several therapeutic approaches, including nucleoside analogues, writer or reader inhibition, substrate‑RNA targeting and tumor‑directed delivery. Experimental combinations can restore drug sensitivity, although simultaneous effects on immune cells or normal tissues may limit systemic treatment. Clinical translation requires relating treatment‑induced RNA changes to drug exposure, tumor selectivity and immune‑cell function, rather than relying on regulator expression alone.
    Keywords:  epitranscriptomics; m5C RNA methylation; metabolic reprogramming; therapeutic resistance; tumor microenvironment
    DOI:  https://doi.org/10.3892/ijmm.2026.6019
  12. Methods Mol Biol. 2027 ;3083 45-68
      Translation regulation enables precise control of protein expression levels. In prokaryotes, regulatory RNAs and RNA-binding proteins (RBPs) can modulate ribosome activity at the level of translation initiation. Here, we examine the computational design of RBP-based translation regulation systems. We first present a systematic exploration of protein databases and genomic datasets to identify candidate regulatory RBPs. We then describe the design of target RNA sequences required to achieve distinct regulatory behaviors. We show how model-based experimental characterization provides quantitative insight into regulatory performance and enables rational comparison among different designs. Finally, we present omics-based approaches to evaluate the orthogonality of the engineered systems within the host organism. Overall, our procedure outlines the main stages for engineering RBP-mediated translation control and provides a synthetic biology framework for programming bacterial cells.
    Keywords:  Bacterial networks; Orthogonal regulation; Post-transcriptional regulation; RNA recognition motif (RRM)
    DOI:  https://doi.org/10.1007/978-1-0716-5583-2_4
  13. Cells. 2026 Oct 10. pii: 1838. [Epub ahead of print]15(20):
      SUMOylation is a reversible post-translational modification that regulates protein stability, localization, activity, and protein-protein interactions. In the cardiovascular system, SUMO signaling intersects with oxidative stress, mitochondrial homeostasis, calcium handling, inflammatory activation, and stress-induced transcriptional reprogramming. Here, we review the molecular architecture of the SUMO system and its redox sensitivity and integrate evidence for SUMO-dependent regulation of mitochondrial quality control, metabolic adaptation, inflammatory responses, and regulated cell death. We further examine how these mechanisms contribute to atherosclerosis, myocardial ischemia-reperfusion injury, cardiac remodeling, heart failure, arrhythmia, and pulmonary vascular disease, while distinguishing evidence that is mechanistic, correlative, or contradictory. Based on this evidence, we propose a stress-responsive SUMO rheostat framework in which the functional output of SUMO signaling is shaped not simply by the magnitude of stress, but by the interplay among stress intensity and duration, subcellular compartment, substrate accessibility and abundance, SUMO paralogue composition, enzyme activity, cell identity, and disease stage. These contextual variables can influence which SUMO-regulated substrates are accessible to individual enzymes, where modification occurs, and how long it persists, thereby contributing to divergent functional outcomes under otherwise similar stress conditions. The framework is intended as a conceptual synthesis for reconciling seemingly divergent effects of SUMOylation across cardiovascular diseases rather than as a quantitatively validated stress-SUMO response model. Finally, we discuss the translational challenges and opportunities of moving beyond global modulation of the SUMO pathway toward substrate-selective, enzyme-selective, and cell-targeted therapeutic strategies.
    Keywords:  SUMOylation; cardiac remodeling; cardiovascular disease; inflammation; ischemia–reperfusion injury; mitochondria; oxidative stress
    DOI:  https://doi.org/10.3390/cells15201838
  14. RNA. 2026 Oct 29. pii: rna.081163.126. [Epub ahead of print]
      N6-methyladenosine (m⁶A), the most prevalent internal modification in mammalian mRNA, contributes to post-transcriptional gene regulation, yet how m⁶A presence and modification intensity relate to gene expression during development remains incompletely understood. Here, by integrating m⁶A-seq, RNA-seq, IGF2BP2 RIP-seq, and Ribo-seq data across developmental trajectories of murine heart and liver, we identify a genome-wide presence-dosage pattern of m⁶A-associated gene regulation. m⁶A-modified transcripts generally show higher baseline expression than unmodified transcripts, whereas increasing modification intensity within m⁶A-modified transcripts is associated with reduced transcript abundance. This dual pattern is linked to the binding behavior of the m⁶A reader IGF2BP2: IGF2BP2 occupancy is enriched on m⁶A-modified transcripts but decreases with higher methylation intensity. Structural equation modeling further supports layered associations among m⁶A status, IGF2BP2 binding, transcript abundance, and ribosome occupancy. Regional analysis of m⁶A peaks also suggests position-dependent relationships with translation efficiency, with 3' UTR m⁶A associated with higher TE and CDS m⁶A associated with lower TE. Together, our study provides a quantitative multi-omic framework for understanding how m⁶A presence and dosage are associated with gene expression and translation during tissue development, and suggests IGF2BP2 binding as a potential mediator of these relationships.
    Keywords:  IGF2BP2; RNA modification; epitranscriptomics; m⁶A methylation; ribosome profiling
    DOI:  https://doi.org/10.1261/rna.081163.126
  15. bioRxiv. 2026 Sep 03. pii: 2026.09.01.748611. [Epub ahead of print]
      Maintenance of cellular homeostasis requires tight coordination between protein synthesis and degradation, particularly at old age and under conditions of stress including starvation. Autophagy contributes to sustain this balance by degrading cytoplasmic proteins and organelles. It thus is essential to prevent the accumulation of damaged proteins and organelles and to recycle nutrients. Of the three forms of autophagy, macroautophagy, chaperone mediated autophagy, and (endosomal) microautophagy (e-MI), the latter remains the least well understood. During e-MI, cytosolic substrate proteins are captured into late endosomes via ESCRT-dependent multivesicular body formation and then degraded in late endosomes or lysosomes. e-MI is thought to contribute to protein quality control under basal conditions and under stress. Importantly, very little is known about the endogenous substrates of e-MI in flies and thus about its physiological role. Performing integrative multi-omic analyses in Drosophila larval fat body that has functions similar to mammalian liver and adipose tissue, we identified 153 high-confidence endogenous e-MI substrates with the degradation of ribosomal proteins by e-MI being the most strongly affected functional category. Generally, we found that starvation caused the depletion of proteins involved in translation, aminoacyl-tRNA synthesis, and ribosomal biogenesis, without affecting their level of transcripts. Importantly, we observe a striking specificity between e-MI and macroautophagy, as the two pathways largely target distinct protein sets including different subsets of ribosomal proteins. Our metabolomic analysis further shows that genetic inhibition of e-MI reverses the reduced levels of amino acid caused by starvation. Together, our findings reveal ribosome turnover as a central physiological function of Drosophila e-MI and establish e-MI as a pathway driving metabolic adaptation during starvation.
    HIGHLIGHTS: Proteomic and metabolomic analysis of Drosophila fat body under starvation stress Systematic identification of endosomal microautophagy (e-MI) substrates.Ribosomal proteins are a major target of e-MI.e-MI and macroautophagy degrade distinct proteins incl. different ribosomal ones.Prolonged starvation alters amino acid levels.
    DOI:  https://doi.org/10.64898/2026.09.01.748611
  16. Adv Sci (Weinh). 2026 Oct 22. pii: e78345. [Epub ahead of print]
      tRNA-derived small RNAs (tsRNAs) regulate gene expression and cellular stress responses in cancer, but their roles in colorectal cancer (CRC) progression and chemotherapy response remain incompletely understood. Dysregulated tsRNAs in CRC were identified by RNA sequencing. The functions of tRF5-GlyTCC were evaluated using in vitro assays and an in vivo xenograft model. Its targets and molecular effects were investigated by bioinformatic analyses, luciferase reporter assays, western blotting, and immunofluorescence. m5C modification was assessed by MeRIP-qPCR. tRF5-GlyTCC was downregulated in CRC tissues and associated with advanced disease and poor prognosis. Restoration of tRF5-GlyTCC suppressed CRC cell growth and migration in vitro and tumor growth in vivo. tRF5-GlyTCC interacted with the RPL23 3'UTR and was associated with altered ribosomal homeostasis, nucleolar stress, p53 signaling, and autophagy. Restoration of tRF5-GlyTCC enhanced 5-FU sensitivity, while its agomir increased the antitumor effect of 5-FU in vivo. NSUN3-mediated m5C modification contributed to tRF5-GlyTCC stability. NSUN3-mediated m5C modification contributes to tRF5-GlyTCC stability, which is associated with ribosomal homeostasis, nucleolar stress responses, and p53 signaling. This network contributes to tumor suppression and chemotherapy response in CRC.
    Keywords:  5‐FU; CRC; NSUN3; RPL23; autophagy; m5C; nucleolar stress; tsRNA
    DOI:  https://doi.org/10.1002/advs.78345
  17. Semin Hematol. 2026 Oct 01. pii: S0037-1963(26)00095-8. [Epub ahead of print]
      Hematopoietic stem cells (HSCs) sustain lifelong blood production through a fine balance between self-renewal and differentiation that demands a tight regulation of protein synthesis. HSCs are highly sensitive to translational perturbation, as exemplified by human ribosomopathies-a group of congenital bone marrow failure syndromes caused by mutations in ribosomal components and biogenesis factors. While the contribution of ribosome numbers to hematologic disease is established, ribosome composition is emerging as an equally important axis of regulation. A central source of this compositional diversity is ribosomal RNA (rRNA) nucleotide modifications-human rRNAs carry over 200 chemical modifications, primarily 2'-O-methylation and pseudouridylation, which were long regarded as static structural features but are now recognized as dynamically regulated during cellular differentiation. Perturbation of these modification patterns has profound consequences. In dyskeratosis congenita, germline mutations to rRNA modification-related proteins disrupt rRNA modifications landscape, and cause bone marrow failure through selective translational defects without globally compromising ribosomes numbers. Conversely, in acute myeloid leukemia, leukemic stem cells actively maintain high rRNA modification levels at specific sites to sustain self-renewal, metabolic fitness, and chemoresistance, effectively driving a stem-like translational state. In this review, we integrate findings from normal hematopoietic differentiation, congenital bone marrow failure syndromes, and leukemia to describe how rRNA modifications link translation to cell fate in the hematopoietic system. We discuss the dynamics of rRNA modifications as determinants of cellular identity and highlight emerging therapeutic opportunities, as well as the significant gaps that remain in this expanding field.
    Keywords:  Hematopoiesis; Hematopoietic stem cells; Leukemia; Ribosomes; rRNA modifications
    DOI:  https://doi.org/10.1053/j.seminhematol.2026.09.008
  18. Int J Mol Sci. 2026 Oct 15. pii: 9146. [Epub ahead of print]27(20):
      Heat shock activates heat shock factor 1 (HSF1), which induces classical heat shock genes and promotes transcription of pericentromeric HSAT3 repeats that contribute to nuclear stress body (nSB) formation. Although well characterized in epithelial cells, this response remains poorly understood in myeloid cells. We compared heat-induced HSAT3 transcription and nSB assembly in epithelial and monocytic cell lines, using A549 and THP-1 as models. pHSF1 (Ser326) levels, HSPA1A and HSAT3 expression, and nSB formation were assessed by Western blotting, qPCR, immunofluorescence, RNA-FISH, and 5-ethynyluridine labeling. Heat shock increased pHSF1 (Ser326) levels and HSPA1A expression in both models. A549 cells showed increased HSAT3 transcript levels and prominent nSB formation, whereas undifferentiated THP-1 cells showed little immediate change in HSAT3 transcript levels and did not form prominent nSBs. 5-EU labeling revealed discrete nascent RNA foci in heat-shocked A549, but not THP-1, cells. These foci overlapped with HSF1 and were associated with HSAT3-related hybridization signals. However, click chemistry increased accessibility of genomic satellite sequences, limiting RNA-specific interpretation of the HSAT3 probe signal. PMA-induced differentiation enabled an increase in HSAT3 transcript levels during heat shock and nSB assembly. These findings identify cellular state as a determinant of heat shock-induced satellite transcription and nSB assembly.
    Keywords:  HSF1; cell stress; heat shock; human satellite 3; non-coding RNA; nuclear stress bodies
    DOI:  https://doi.org/10.3390/ijms27209146
  19. Sci Signal. 2026 Oct 27. 19(961): eaen4305
      A bacterial effector inhibits translation of host mRNAs by chemically modifying them.
    DOI:  https://doi.org/10.1126/scisignal.aen4305
  20. Plant Cell Rep. 2026 Oct 28. pii: 346. [Epub ahead of print]45(11):
      Gamma-aminobutyric acid (GABA), a ubiquitous non-protein amino acid, has emerged as an important integrative metabolite and signaling regulator in plants. Initially studied mainly as an intermediate of carbon and nitrogen metabolism, GABA is now known to participate in developmental regulation and stress responses. Its cellular abundance is shaped primarily by the GABA shunt and polyamine-degradation pathways and is further controlled by Ca2+/calmodulin signaling, pH, transcriptional regulation, transport, and environmental cues. GABA has been associated with seed germination, vegetative growth, reproductive development, and fruit ripening, but the strength of evidence differs among processes. Direct molecular evidence for GABA signaling is best established for regulation of aluminum-activated malate transporter (ALMT) anion channels, whereas many reported interactions with phytohormones, redox signals, and stress responses are supported mainly by genetic, pharmacological, metabolic, or exogenous-application studies. Under drought, salinity, temperature extremes, metal stress, and pathogen challenge, changes in endogenous GABA metabolism and exogenous GABA application are frequently associated with improved osmotic adjustment, antioxidant capacity, ion homeostasis, and stress-responsive metabolism. This review synthesizes current knowledge of GABA metabolism, transport, developmental functions, signaling crosstalk, and stress adaptation. To connect these areas without overstating causality, we propose a three-layer GABA-centered working framework comprising upstream regulation of GABA homeostasis, GABA-dependent metabolic and transport processes, and downstream hormonal and physiological reprogramming. We also identify major unresolved questions concerning GABA perception beyond ALMTs, subcellular compartmentalization, direct molecular targets, context-dependent responses, and translation to field applications.
    Keywords:  Hormone interactions; Plant growth and development; Stress resistance; γ-Aminobutyric acid (GABA)
    DOI:  https://doi.org/10.1007/s00299-026-04034-x
  21. Mol Med Rep. 2026 Dec;pii: 338. [Epub ahead of print]34(6):
      Liquid‑liquid phase separation (LLPS) enables RNA‑binding proteins (RBPs) to assemble into dynamic biomolecular condensates that influence post‑transcriptional regulation. In hepatocellular carcinoma (HCC), these condensates may alter RNA processing and stability. They can also influence transcript localization and translational output. Through these effects, RBP condensates may contribute to tumor growth and metastatic progression. They may further support metabolic adaptation, immune evasion and resistance to therapy. The present review focuses on the intersection between LLPS and post‑transcriptional regulation in HCC. In addition, the present review critically assessed current evidence for RBP condensate function and distinguish direct HCC findings from mechanistic extrapolation. Unresolved questions regarding causality and clinical translation were also discussed. This framework may help clarify how condensate biology contributes to HCC and where therapeutic opportunities remain.
    Keywords:  RNA‑binding proteins; biomolecular condensates; hepatocellular carcinoma; liquid‑liquid phase separation; malignant phenotypes; post‑transcriptional regulation; tumor
    DOI:  https://doi.org/10.3892/mmr.2026.14049
  22. J Chem Theory Comput. 2026 Oct 27. 22(20): 10988-11003
      The three human YTH-domain family proteins (YTHDF1, YTHDF2, and YTHDF3) are highly homologous and recognize the N6-methyladenosine (m6A) modification of mRNA with essentially identical binding modes and affinities. This homogeneity challenges the well-established view that different YTHDF proteins play distinct cellular functions (the specificity view), with an emerging argument that these proteins may instead play redundant roles. To study this apparent discrepancy, we investigated the mechanism of binding of m6A-containing RNA using mutagenesis, X-ray crystallography, isothermal titration calorimetry (ITC), and molecular dynamics simulations. Specifically, we compared different properties of YTHDF proteins, including their binding capacities to m6A-RNA, conformational changes, and homodimerization propensity. Our results show that the YTHDF proteins share an identical binding mode of m6A-RNA, which requires rare protonation of m6A for binding. Additionally, the three proteins share a similar open-closed switch for their recognition loop regulating the m6A binding. On the other hand, ITC data and crystal structures provide consistent evidence that the YTHDF proteins differ significantly in the flexibility of the recognition loop and its conformational preferences. Only YTHDF1 can homodimerize, which prevents binding to m6A-RNA. Furthermore, we integrate the available biophysical and biochemical evidence to define both the shared and distinct features of YTHDF1-3 in m6A-RNA recognition and propose a hybrid model that reconciles the redundancy-specificity debate. Finally, we discuss the limitations of the work and propose experiments for validating the presented model.
    DOI:  https://doi.org/10.1021/acs.jctc.6c01247
  23. Tissue Cell. 2026 Oct 17. pii: S0040-8166(26)00763-9. [Epub ahead of print]104(Pt 3): 104067
       PURPOSE: Dry eye disease (DED) is characterized by tear hyperosmolarity, which disrupts corneal epithelial homeostasis and barrier integrity. Membrane-associated mucin 16 (MUC16) is a major component of the ocular surface glycocalyx; however, the post-transcriptional mechanisms linking hyperosmotic stress to MUC16 suppression remain incompletely understood. This study investigated whether the RNA-binding protein Ras-GTPase-activating protein-binding protein 1 (G3BP1), a central component of stress granules (SGs), contributes to MUC16 dysregulation and corneal epithelial barrier dysfunction under hyperosmotic stress.
    METHODS: Immortalized human corneal epithelial cells (HCECs) were exposed to hyperosmotic media (450-550 mOsm/kg). G3BP1 expression, SG assembly, MUC16 mRNA and protein expression, and MUC16 mRNA stability were evaluated using quantitative real-time PCR, western blotting, immunofluorescence, and actinomycin D chase assays. G3BP1 was silenced using siRNA, and G3BP1-MUC16 RNA association was assessed by RNA immunoprecipitation followed by quantitative PCR (RIP-qPCR). Corneal epithelial barrier function was evaluated by transepithelial electrical resistance, sodium fluorescein permeability, and analysis of ZO-1 and Occludin. Computational docking and molecular dynamics simulations were used to investigate the structural plausibility and dynamic stability of a predicted G3BP1-MUC16 RNA interaction.
    RESULTS: Hyperosmotic stress increased G3BP1 mRNA and protein expression and promoted the formation of cytoplasmic G3BP1/TIA-1-positive puncta consistent with SG assembly. In parallel, MUC16 mRNA and protein expression were reduced, showing an inverse association with G3BP1 levels. G3BP1 knockdown partially restored MUC16 expression and transcript stability under hyperosmotic conditions. RIP-qPCR demonstrated enrichment of MUC16 transcripts in G3BP1 immunoprecipitates, supporting an association between G3BP1-containing ribonucleoprotein complexes and MUC16 mRNA. Hyperosmotic stress impaired epithelial barrier function, as indicated by reduced transepithelial electrical resistance, increased fluorescein permeability, and disruption of tight-junction-associated proteins; these alterations were partially improved by G3BP1 silencing. Computational analyses supported the structural plausibility and dynamic stability of the predicted protein-RNA complex.
    CONCLUSIONS: Hyperosmotic stress is associated with increased G3BP1 expression, stress granule assembly, and post-transcriptional suppression of MUC16 in corneal epithelial cells. The findings support a G3BP1-dependent contribution to MUC16 transcript destabilization and epithelial barrier dysfunction. However, whether stress granule assembly is required for MUC16 repression and whether G3BP1 directly binds MUC16 RNA through the predicted structural interface require further experimental validation.
    Keywords:  Corneal epithelial barrier; Dry eye disease; G3BP1; Glycocalyx; Hyperosmotic stress; MUC16; Molecular dynamics; Post-transcriptional regulation; RNA-binding protein; Stress granules
    DOI:  https://doi.org/10.1016/j.tice.2026.104067
  24. bioRxiv. 2026 Oct 09. pii: 2026.10.08.757657. [Epub ahead of print]
      Translation of defective mRNA transcripts can lead to the formation of stalled "non-stop" ribosome complexes. To rescue these ribosomes, bacteria have evolved a mechanism called trans -translation that is mediated by transfer-messenger RNA (tmRNA) and small protein B (SmpB). During the translocation step of trans -translation, the stalled mRNA is ejected and the reading frame found in the mRNA-like domain (MLD) of tmRNA is loaded into the mRNA channel. The ribosome then translates the new template, thereby tagging the nascent protein for degradation. While structures of tmRNA-SmpB on the ribosome have been available for years, little is known about the molecular factors that govern the dynamics of tmRNA translocation. Here, we use an energetically smooth model (i.e. SMOG) to simulate translocation of tmRNA-SmpB, which reveals that the structure of the ribosome gives rise to a preferred sequence of conformational substeps. Specifically, the tRNA-like domain (TLD) translocates, then the MLD loads, and finally the C-terminal tail of SmpB rearranges. These steps are interdependent and associated with a range of sterically-induced barriers that regulate the kinetics. This provides a structural and energetic framework for understanding, and ultimately controlling, the dynamics of trans -translation.
    DOI:  https://doi.org/10.64898/2026.10.08.757657
  25. Cells. 2026 Oct 15. pii: 1883. [Epub ahead of print]15(20):
      Upon dysfunction of the endoplasmic reticulum (ER), namely ER stress, eukaryotic cells commonly change their gene expression profile, resulting in enhanced ER functions. This cytoprotective response is called the unfolded protein response (UPR), whose molecular mechanism was first elucidated in pioneering studies using Saccharomyces cerevisiae. Ire1 is a transmembrane endoribonuclease that acts as an ER stress sensor. While Ire1-dependent unconventional splicing of mRNA encoding Hac1, the transcription factor responsible for UPR, was discovered in the 1990s, the precise mechanisms regulating their production and activation remain under investigation. Studies on Ire1 and Hac1 in other ascomycetes have also advanced, partly from the perspectives of clinical science and industrial applications, thereby uncovering some significant functional differences from those in S. cerevisiae. For instance, many ascomycete species other than S. cerevisiae likely perform regulated Ire1-dependent decay (RIDD), in which mRNAs encoding ER-client proteins are digested to mitigate ER stress. In certain species, Ire1 may preferentially shift its output toward HAC1 mRNA splicing or RIDD, depending on the type of stimulus. This review article provides an overview of classic and recent findings on the regulation and function of Ire1 and its target mRNAs in various ascomycete species.
    Keywords:  RNA; endoplasmic reticulum; fungi; stress response; yeast
    DOI:  https://doi.org/10.3390/cells15201883
  26. Nutrients. 2026 Oct 15. pii: 3382. [Epub ahead of print]18(20):
      Sulfur amino acids (SAAs), mainly methionine and cysteine, play an important role in coordinating nutrient sensing, one-carbon metabolism, redox regulation, and whole-body energy homeostasis. Dietary methionine restriction (MR) and sulfur amino acid restriction (SAAR) have gained increasing interest as nutritional interventions that produce pronounced metabolic benefits in preclinical models, including reductions in adiposity and hepatic lipid accumulation and improvements in insulin sensitivity and glucose regulation. Human intervention studies suggest biological activity and potential metabolic benefit, although the available clinical evidence remains limited and heterogeneous. These effects arise from the coordinated activation of multiple nutrient-responsive pathways. Reduced amino acid availability can stimulate the general control nonderepressible 2-eukaryotic translation initiation factor 2 alpha-activating transcription factor 4 signaling pathway (GCN2-eIF2α-ATF4) integrated stress response, whereas changes in methionine-derived S-adenosylmethionine modulate mechanistic target of rapamycin complex 1 (mTORC1) activity through S-adenosylmethionine sensor upstream of mTORC1 (SAMTOR)-dependent signaling. At the systemic level, hepatic fibroblast growth factor 21 contributes to the regulation of adipose tissue remodeling, energy expenditure, thermogenesis, and insulin sensitivity. At the same time, alterations in transsulfuration reshape cysteine utilization, glutathione metabolism, hydrogen sulfide signaling, and mitochondrial redox adaptation. Importantly, selective MR, broader SAAR, and total protein restriction should not be considered equivalent interventions, as their metabolic effects are influenced by cysteine availability and the degree of restriction. Nevertheless, the translation of these effects to humans remains incompletely established, and available intervention studies are limited in number, duration, and sample size. This review examines the biochemical and molecular mechanisms underlying SAA sensing and metabolic adaptation and evaluates their potential relevance to obesity, type 2 diabetes, metabolic syndrome, and metabolic dysfunction-associated steatotic liver disease, with particular emphasis on future applications in precision nutrition.
    Keywords:  FGF21; GCN2–eIF2α–ATF4; SAMTOR–mTORC1; cysteine; metabolic adaptation; methionine; precision nutrition; redox homeostasis; sulfur amino acid restriction; sulfur amino acids
    DOI:  https://doi.org/10.3390/nu18203382
  27. Cells. 2026 Oct 16. pii: 1888. [Epub ahead of print]15(20):
      Impaired ribosome biogenesis (RiBi) triggers the impaired ribosome biogenesis checkpoint (IRBC), a nucleolar stress pathway that stabilizes p53 and induces cellular senescence. Whether RiBi dysfunction directly drives renal interstitial fibrosis (RIF) remains unknown. Here, we combined human IgA nephropathy biopsies, murine fibrosis models, and cultured proximal tubular epithelial cells treated with the RNA polymerase I inhibitor CX5461, the p53 inhibitor pifithrin-α, siRNA-mediated POLR1A knockdown, and the DNA-damaging agent etoposide to dissect the RiBi-IRBC-p53-senescence axis. We identified defective rDNA transcription in the proximal tubules of fibrotic human kidneys and in experimental fibrosis models. Pharmacological RiBi inhibition with CX5461 induced RIF prior to functional decline. Mechanistically, RiBi impairment promoted RPL5/RPL11 binding to HDM2, stabilized p53, upregulated p21, and induced G2/M arrest, which was rescued by pifithrin-α. Genetic silencing of POLR1A recapitulated IRBC activation and senescence without causing DNA damage. Time-course analysis showed only marginal γ-H2AX elevation by CX5461 versus robust induction by etoposide. Importantly, etoposide-induced DNA damage failed to enhance RPL5/RPL11-HDM2 binding, suggesting that IRBC activation is not a general consequence of the DNA damage response. Collectively, impaired RiBi drives RIF mainly through the IRBC-p53-senescence axis under our experimental conditions, providing a mechanistic framework for understanding organ toxicities associated with RNA Pol I inhibition.
    Keywords:  DNA damage response; cellular senescence; impaired ribosome biogenesis checkpoint; kidney fibrosis; p53; ribosome biogenesis
    DOI:  https://doi.org/10.3390/cells15201888
  28. bioRxiv. 2026 Oct 09. pii: 2026.10.08.757597. [Epub ahead of print]
      The genetic code is decoded by a highly redundant transfer RNA (tRNA) repertoire, yet whether this apparent redundancy serves a functional role beyond ensuring robust translation remains un-clear. Here, we establish an atlas of tRNA dependencies through large-scale CRISPRi perturbation mapping across matched in vivo tumor growth and in vitro cell culture for 16 cancer cell lines spanning seven tissue types. During in vivo tumor growth, tRNA dependencies exhibited tissue organization at isodecoder resolution and were associated with codon demand at the isoacceptor level. Strikingly, these relationships were reorganized when cells were cultured in vitro , establishing environmental sensitivity of tRNA dependency-in contrast to protein components of the decoding machinery such as aminoacyl-tRNA synthetases (aaRSs), whose dependencies were largely preserved across environments. Despite pronounced context specificity, environmental alterations in tRNA dependency were dominated by a shared response across cancer cell lines, organized across isoacceptor and isodecoder levels. By disentangling stable cellular identity from environment-associated dependency states, we resolved a shared axis of isoacceptor dependency remodeling and identified specific tRNA isoacceptors associated with promoting or restraining adaptation to the tumor environment. We further connect this functional architecture to differential translation of codon-usage-biased programs associated with proliferation and tumor-microenvironmental stress. Together, our study reveals that tRNA redundancy does not imply functional equivalence, but instead forms a structured and environmentally plastic control layer linking coding information to translational output.
    DOI:  https://doi.org/10.64898/2026.10.08.757597
  29. Nucleic Acids Res. 2026 Oct 24. pii: gkag1060. [Epub ahead of print]54(20):
      The nucleolus is a membrane-less organelle essential for ribosomal DNA (rDNA) transcription and ribosome biogenesis, yet the mechanisms regulating its dynamic assembly remain incompletely understood. Here, we identify the phosphatase protein phosphatase magnesium-dependent 1 delta (PPM1D) as a key regulator of the nucleolar architecture via dephosphorylation of the scaffold protein TCOF1. By combining super-resolution microscopy and domain mapping, we show that PPM1D localizes to the nucleolus through a conserved motif at the C-terminus. Phosphoproteomic analysis and structural modeling revealed that PPM1D targets casein kinase 2 (CK2)-phosphorylated sites within the low-complexity repeat domain of TCOF1, which impacts its interaction with RNA polymerase I (Pol I), immobilization in the fibrillar centres, and nucleolar condensation. Disruption of the phosphorylation balance by loss of PPM1D or inhibition of CK2 leads to nucleolar disorganization and reduced rDNA transcription. Finally, we demonstrate that pharmacological inhibition of PPM1D sensitizes cells to RNA Pol I inhibitors, in both p53-dependent and -independent contexts. Together, we uncover a reversible phosphorylation switch that governs TCOF1 dynamics and its nucleolar function, with potential implications for targeting ribosome biogenesis in cancer.
    DOI:  https://doi.org/10.1093/nar/gkag1060
  30. Cell Death Discov. 2026 Jul 29. pii: 426. [Epub ahead of print]12(1):
      Small Heat Shock Protein Family B (HSPB) members are ATP-independent chaperones essential for maintaining cellular proteostasis. Together with chaperones and co-chaperones such as HSP70 and BAG3, they prevent aberrant protein folding and suppress protein aggregation, particularly under proteotoxic stress. HSPBs have also been extensively linked to neurodegenerative disease and in promoting chemoresistance in cancer. We previously showed that members of the HSPB family can reside within the mitochondrial intermembrane space where they contribute to the maintenance of proteostasis, and that acute cytotoxic stress leads to HSPB sequestration to the outer mitochondrial membrane. Here, we further elucidate this mechanism, demonstrating that HSPB1 is selectively enriched within mitochondria under milder thermal stress condition, exhibiting a pronounced association with the outer mitochondrial membrane. We also observed distinct stress-dependent mitochondrial recruitment profiles across HSPB paralogs, revealing a similar behaviour for HSPB8, whereby HSPB1 responded at a comparatively lower stress threshold, indicating functional specialization within the HSPB family. Inducing this mechanism enhances cell survival during hyperthermic stress, preventing Cytochrome c release, and raising the apoptotic activation threshold in our experimental system. These findings indicate that HSPBs, particularly HSPB1 may contribute to mitochondrial stress adaptation prior to Cytochrome c release. This underexplored mechanism may underlie the modulation of stress-related and degenerative disease progression and contribute to the chemoresistance associated with cancer, which have been attributed to HSPBs.
    DOI:  https://doi.org/10.1038/s41420-026-03268-8
  31. bioRxiv. 2026 Oct 09. pii: 2026.10.07.757281. [Epub ahead of print]
      The progressive collapse of protein homeostasis is a defining feature of aging, yet upstream events deteriorating protein synthesis remain poorly defined. Zinc is an essential micronutrient and structural cofactor, but its role in the aging ribosomal proteome is poorly understood. Here, using Caenorhabditis elegans , we show that the whole-body zinc-to-sulfur ratio declines by ∼90% between day 1 and day 13 of adulthood. Supplementing aged animals with a low dose of ZnCl 2 (10 μM) restored organismal zinc levels and improved healthspan, thermotolerance, and oxidative stress resistance, whereas higher doses were toxic. Quantitative proteomics revealed that structural constituents of the ribosome were the most enriched functional category altered by zinc, accompanied by robust induction of metallothionein MTL-1. Zinc-supplemented animals exhibited increased protein synthesis and a transient increase in ribosomal proteins, while 45S pre-rRNA levels remained unaffected, indicating that zinc acts on ribosome structure rather than biogenesis. Zinc supplementation coordinately reversed the age-associated decline of antioxidant, chaperone, proteasome, and energy-metabolism factors. Furthermore, zinc conferred protection in two proteotoxicity models, suppressing polyglutamine aggregation and delaying amyloid-beta-induced paralysis. Our findings establish that zinc preserves translational proteostasis, identifying late-life zinc supplementation as a translatable micronutrient intervention against age-related proteinopathies.
    DOI:  https://doi.org/10.64898/2026.10.07.757281
  32. Sci Signal. 2026 Oct 27. 19(961): eaed9028
      Transfer RNA (tRNA) modifications are increasingly implicated as posttranscriptional regulators of basic neuronal functions. Characterizing tRNA modification profiles in specific neural circuits that control well-defined behaviors is challenging because of the complexity of conventional neurobiological models. Here, we leveraged the numerically simple central nervous system (CNS) of the marine mollusk Aplysia californica to investigate tRNA modification dynamics during habituation of a defensive reflex. We identified and quantified dozens of tRNA modifications and characterized the distribution of select small RNA modifications across different neuronal and nonneuronal tissues. Upon behavioral habituation of the siphon-elicited siphon withdrawal reflex (SSWR), we found that tRNA modification profiles in the major ganglion that controls the SSWR were repatterned with predictable, learning-related changes. We found a family of anticodon loop modifications that changed with habituation learning, including N6-isopentenyladenosine (i6A), which increased in abundance, and additional modifications N1-methyladenosine (m1A) and N7-methylguanosine (m7G), which decreased. These tRNA modification dynamics occurred independently of changes in the expression of their parent tRNAs, illustrating that behavioral habituation altered the activity of tRNA-modifying enzymes. Overall, our work reveals a link between tRNA modifications and behavioral habituation and provides insights toward understanding the posttranscriptional mechanisms of learning and memory.
    DOI:  https://doi.org/10.1126/scisignal.aed9028
  33. Int J Mol Sci. 2026 Oct 15. pii: 9132. [Epub ahead of print]27(20):
      Nucleolin (NCL) is a highly phosphorylated, multilocalized, pleiotropic nucleolar protein involved in chromatin organization, DNA damage response, the cell cycle, RNA metabolism, and ribosome biogenesis. A large-scale integration of publicly available human cellular phosphoproteome datasets led to the identification of 18 frequently detected/reported phosphosites across 1266 profiling and 507 differential datasets. Amidst various strategies currently being considered to target NCL in cancers, multi-domain distribution of these phosphosites differentially regulated across distinct cancers highlighted its plausible involvement in tumor-associated regulatory mechanisms. This demands the exploration of the potential kinases and interactors associated with these phosphorylation events. We performed a co-occurrence analysis to explore potential coordinated phosphorylation events among them and across other phosphoproteins. An integrative analysis of phosphosite-specific co-regulation, upstream kinases, and interaction networks was employed to explore potential phosphosite-specific signaling associations. Intriguingly, our analysis inferred the association of the predominant phosphosites within the acidic tract with chromatin organization and histone-related functions, whereas TPxKK motif phosphosites were linked to NCL localization, chromosome segregation, and nucleolar reorganization. Phosphosites in the RRM domain showed a potential association with RNA-binding proteins and metabolic pathways. Collectively, these findings suggest a domain-specific phosphosite-centric regulatory network of NCL, providing a valuable reference framework for future experimental studies and phosphosite-directed therapeutic strategies in cancers.
    Keywords:  NCL; RNA metabolism; chromatin organization; phosphoproteomics; phosphosites
    DOI:  https://doi.org/10.3390/ijms27209132
  34. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026 Aug 28. pii: 1672-7347(2026)08-1661-16. [Epub ahead of print]51(8): 1661-1676
       OBJECTIVES: RNA-binding motif protein 15 (RBM15) is a methyltransferase involved in N6-methyladenosine (m6A) modification and has been shown to be associated with the initiation and progression of various malignancies. This study aims to investigate the biological function and underlying mechanism by which RBM15 promotes the progression of cervical squamous cell carcinoma (CSCC) through in vitro and in vivo experiments.
    METHODS: The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were used to analyze differences in the mRNA expression levels of RBM15, aldo-keto reductase family 1 member B10 (AKR1B10), and insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) between CSCC and adjacent non-tumor tissues, as well as the associations of RBM15, AKR1B10, and IGF2BP1 expression with overall survival in patients with CSCC. Real-time PCR and Western blotting (WB) were used to determine the expression levels of RBM15, AKR1B10, and IGF2BP1 in CSCC tissues and adjacent normal tissues. Cell Counting Kit-8 (CCK-8), colony formation, 5-ethynyl-2'-deoxyuridine (EdU) staining, wound-healing, and Transwell migration and invasion assays were performed to investigate the effects of RBM15 knockdown on the proliferation, migration, and invasion of CSCC cells. A nude mouse xenograft model was established to evaluate the effect of RBM15 knockdown on tumor growth. Methylated RNA immunoprecipitation (MeRIP) was performed to assess m6A modification of AKR1B10. RNA immunoprecipitation (RIP) and actinomycin D assays were used to analyze the interactions of RBM15 and IGF2BP1 with AKR1B10 mRNA. Small interfering RNAs (siRNAs), including si-IGF2BP1 and si-YTHDF1, were used to knock down IGF2BP1 or YTH N6-methyladenosine RNA-binding protein F1 (YTHDF1), respectively, and their roles in regulating AKR1B10 mRNA stability were analyzed.
    RESULTS: Analysis of TCGA and GEO data showed that the mRNA and protein expression levels of RBM15, AKR1B10, and IGF2BP1 were significantly up-regulated in CSCC tissues (all P<0.05), and high expression of RBM15, AKR1B10, and IGF2BP1 was significantly associated with poor prognosis in patients with CSCC (all P<0.05). In vitro experiments showed that RBM15 knockdown inhibited the proliferation, invasion, and migration of CSCC cells, while in vivo experiments showed that RBM15 knockdown inhibited tumor growth (all P<0.05). MeRIP and actinomycin D assays showed that RBM15 knockdown significantly reduced the m6A methylation level of AKR1B10 and decreased its mRNA stability. RIP assays showed that RBM15 knockdown significantly reduced the binding of RBM15 and IGF2BP1 to AKR1B10 mRNA (all P<0.05). IGF2BP1-dependency experiments showed that si-IGF2BP1 treatment significantly decreased AKR1B10 mRNA expression (P<0.05), whereas no significant change was observed in the si-YTHDF1 group (P>0.05).
    CONCLUSIONS: RBM15-mediated m6A modification promotes CSCC progression through the IGF2BP1-AKR1B10 axis. RBM15 may serve as a potential biomarker for predicting outcomes in patients with CSCC.
    Keywords:  AKR1B10; IGF2BP1; N 6-methyladenosine; RBM15; cervical squamous cell carcinoma; mRNA stability
    DOI:  https://doi.org/10.11817/j.issn.1672-7347.2026.250169
  35. Biol Direct. 2026 Jul 30. pii: 216. [Epub ahead of print]21(1):
       BACKGROUND: Prostate cancer (PCa) remains a major clinical challenge, particularly because of its progression to more aggressive disease states, and the molecular mechanisms driving its progression are still incompletely understood. KH-type splicing regulatory protein (KHSRP) is a multifunctional RNA-binding protein involved in post-transcriptional gene regulation, but its role and downstream regulatory mechanisms in PCa remain unclear.
    METHODS: The clinical relevance of KHSRP in PCa was assessed using public datasets and patient specimens. We assessed the biological functions of KHSRP in vitro and in vivo, identified DUSP6 by integrative RNA-seq and RIP-seq analyses, and further validated the associated signaling and phenotypic changes using Western blotting and functional assays.
    RESULTS: KHSRP was significantly upregulated in PCa and was associated with aggressive clinicopathological features and poor prognosis. Functional experiments showed that KHSRP overexpression promoted proliferation, migration, and invasion while suppressing apoptosis in PCa cells, whereas KHSRP knockdown produced the opposite effects. Mechanistically, integrative RNA-seq and RIP-seq analyses identified DUSP6 as a candidate downstream target of KHSRP. Further validation using RNA immunoprecipitation assays and RNA decay assays demonstrated that KHSRP accelerated DUSP6 mRNA decay and repressed DUSP6 expression at the post-transcriptional level. Reduced DUSP6 expression was accompanied by enhanced ERK phosphorylation and coordinated activation of PI3K/AKT/mTOR signaling. Restoration of DUSP6 attenuated the pro-tumorigenic effects of KHSRP and weakened the associated signaling activation. Xenograft assays further confirmed the tumor-promoting role of KHSRP in vivo.
    CONCLUSION: KHSRP drives PCa progression through a DUSP6-dependent signaling axis by repressing DUSP6 at the post-transcriptional level and facilitating coordinated activation of ERK and PI3K/AKT/mTOR signaling. These findings identify a previously unrecognized KHSRP-DUSP6 regulatory axis in PCa and suggest that KHSRP may serve as a potential therapeutic target.
    Keywords:  DUSP6; KHSRP; Prostate cancer; RNA binding protein
    DOI:  https://doi.org/10.1186/s13062-026-00894-1
  36. J Gen Virol. 2026 Oct;107(10):
      The Crimean-Congo haemorrhagic fever virus nucleocapsid (N) protein contains structurally distinct stalk and head domains. The mRNA encoding N protein (NP) possesses a 55-nt 5' UTR that folds into a stable hairpin structure. We previously demonstrated that the NP preferentially promotes translation of its own mRNA by simultaneously binding the 5' UTR hairpin via its stalk domain and the translation initiation factor eIF4A via its head domain. This coordinated interaction facilitates selective ribosome recruitment to the 5' UTR and enhances translation of the downstream ORF. In this study, we further show that the S-segment 5' UTR functions as an internal ribosome entry site (IRES)-like element when inserted between two ORFs, promoting downstream translation in an NP-dependent manner. Expression of a dual-reporter transcript containing the S-segment 5' UTR in Hazara virus-infected cells inhibited viral replication by competing for NP binding. In contrast, randomization of the 5' UTR abolished NP binding, IRES-like activity and antiviral effects. Unlike the S segment, the L- and M-segment 5' UTRs do not form the requisite hairpin structure, fail to bind NP and cannot support NP-mediated translation. These findings suggest that structurally similar elements within host mRNAs may also be selectively translated during infection.
    Keywords:  Crimean–Congo haemorrhagic fever virus; internal ribosome entry site (IRES); nucleocapsid protein; translation
    DOI:  https://doi.org/10.1099/jgv.0.002359
  37. Cancers (Basel). 2026 Oct 17. pii: 3358. [Epub ahead of print]18(20):
      Clear cell renal cell carcinoma (ccRCC) is the most prevalent form of RCC and is defined by loss of von Hippel-Lindau (VHL) function and dysregulated hypoxia signaling. Hyperactivation of the mTOR pathway is also frequently observed. These factors increase anabolic and protein-synthetic demand leading to proteotoxic stress. To survive under these conditions, ccRCC cells rely on adaptive endoplasmic reticulum (ER) stress responses and autophagy to maintain proteostasis. Regulated in Development and DNA Damage Response 1 (REDD1, also known as DDIT4) is a key stress response protein that integrates hypoxic, metabolic, and ER stress signals to regulate mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) activity and redox homeostasis. REDD1 can either suppress tumor growth through mTOR inhibition or promote survival by facilitating oxidative stress tolerance and autophagy depending on the specific context. In ccRCC, REDD1 expression is driven by VHL loss and HIF stabilization. Yet, mTORC1 activity frequently persists due to dysregulation of upstream repressors such as TSC1/TSC2, direct activating mutations in mTOR, and enhanced growth factor signaling. This paradox underscores the complex interplay between REDD1 and the oncogenic signaling landscape of RCC. Here, we review emerging evidence positioning REDD1 as a pivotal link between hypoxia, mTOR signaling, and ER stress in ccRCC and discuss how therapeutic modulation of this pathway through ER stress inducers, proteasome inhibitors, and p97/valosin-containing protein (VCP) inhibitors may overcome adaptive resistance and improve patient outcomes.
    Keywords:  CB-5339; REDD1; clear-cell renal cell carcinoma; endoplasmic reticulum stress; p97/VCP inhibitors; proteostasis; targeted therapeutics; therapeutic resistance; unfolded protein response
    DOI:  https://doi.org/10.3390/cancers18203358
  38. Nat Cell Biol. 2026 Oct 29.
      Although mRNA decoding efficiency influences protein synthesis, it remains unknown whether the translation elongation machinery harbours intrinsic mechanisms that selectively modulate codon decoding to shape proteomes. Here we show that METTL13-catalysed dimethylation of the elongation factor eEF1A at lysine 55 (eEF1AK55me2) enhances decoding of select codons, preferentially increasing pro-oncogenic protein synthesis to promote tumorigenesis and targeted therapy resistance. Proteomic profiling and single-molecule imaging reveal that eEF1AK55me2 increases decoding efficiency, particularly for under-represented codons with weak wobble-position base pairing. In cancer cells, METTL13 knockdown reduced translation of oncogenic mRNA enriched in eEF1AK55me2-dependent codons, including KRAS; synonymous recoding with eEF1AK55me2-independent codons reversed this effect. METTL13 loss inhibited the growth of KRASG12C inhibitor (sotorasib)-resistant lung adenocarcinoma syngeneic tumours and patient-derived xenografts. In relapsed autochthonous KRASG12C-driven lung adenocarcinoma, METTL13 ablation mitigated sotorasib resistance and significantly extended survival in vivo. Among patients receiving a KRASG12C inhibitor, inferred METTL13 activity was associated with inferior clinical response. These findings identify an eEF1AK55me2-mediated mRNA decoding mechanism promoting selective oncogenic protein synthesis and suggest METTL13 targeting may counteract KRAS-inhibitor resistance.
    DOI:  https://doi.org/10.1038/s41556-026-02085-6
  39. J Tradit Chin Med. 2026 Oct;46(5): 1082-1095
       OBJECTIVE: To investigate the therapeutic effects and mechanisms of baicalein (BAI) on asthma based on the gut-lung axis theory.
    METHODS: This study utilized BALB/C mice, four-dimensional independent data acquisition proteomics, molecular docking, molecular dynamics simulation, and immunohistochemistry to explore how BAI affects ribosome biogenesis in the gut of asthmatic mice.
    RESULTS: We investigated the regulatory effects of BAI on intestinal proteins, and we identified 93 differentially expressed proteins (DEPs) that overlapped among the control group, model group, and BAI (H) group. These proteins were predominantly involved in translation, cytosolic ribosomes, and structural constituents of ribosomes. BAI treatment significantly regulated the ribosome pathway. Eight ribosome biogenesis-related proteins [small ribosomal subunit protein uS9m (MRPS9), ribosomal protein L28 (RPL28), ribosomal protein L32 (RPL32), ribosomal protein S15A (RPS15A), ribosomal protein S23 (RPS23), RNA polymerase I and III subunit C (POLR1C), ribosomal protein L23A (RPL23A), and ribosomal protein S25 (RPS25)] were significantly correlated with pulmonary inflammatory factors. Molecular docking confirmed that RPS25, RPL23A, and POLR1C were primary targets of BAI. Molecular dynamics simulations revealed that the RPL23A-BAI complex exhibited greater structural stability than the RPS25-BAI and POLR1C-BAI complexes. Immunohistochemistry further verified that BAI suppressed the protein expression of RPS25, RPL23A, and POLR1C in the colon.
    CONCLUSIONS: These results underscore that the mechanism by which BAI alleviates asthma may involve the regulation of ribosome biogenesis in colonic tissue.
    Keywords:  allergic asthma; baicalein; colon; ribosome biogenesis
    DOI:  https://doi.org/10.19852/j.cnki.jtcm.2026.05.003
  40. Nephrol Dial Transplant. 2026 Oct 23. pii: gfag251. [Epub ahead of print]
      Circular RNAs (circRNAs) are covalently closed RNA molecules generated through back-splicing of precursor mRNA (pre-mRNA) transcripts. Although circRNAs lack the 5' cap and the 3' poly(A) tail characteristic of linear mRNAs, their circular structure confers enhanced stability and resistance to exonucleolytic degradation, establishing circRNAs as important regulators of gene expression that contribute to cellular homeostasis and disease progression. CircRNAs regulate gene expression at multiple levels through miRNA sequestration, modulation of RNA-binding protein (RBP) activity, regulation of transcription and splicing, and even translation into functional micropeptides, with emerging evidence supporting their involvement in the splicing machinery. Here, we will review current knowledge on circRNA biogenesis and function, mainly focusing on their impact on the transition from inflammation to tissue repair, fibrotic remodeling, and disease progression. Special attention is devoted to circRNA-mediated regulatory networks in renal disease while placing these findings within the broader context of fibrotic and inflammatory disorders affecting multiple organs. We further examine the potential of circRNAs as stable, tissue-specific biomarkers and therapeutic targets, while highlighting the emerging use of endogenous and engineered circRNAs as platforms for RNA-based therapeutics and vaccines. By integrating mechanistic insights with functional and translational perspectives, this review provides a framework for understanding circRNAs as active components of RNA regulatory networks and outline the key challenges and opportunities for their future clinical translation.
    Keywords:  RNA therapeutics; RNA-Binding Proteins; biomarkers; circRNAs; fibrosis; inflammation; kidney disease; miRNAs; spliceosome; tissue remodeling
    DOI:  https://doi.org/10.1093/ndt/gfag251
  41. Biochem Biophys Res Commun. 2026 Oct 24. pii: S0006-291X(26)01572-X. [Epub ahead of print]841 154806
      Nucleolar proteins support ribosome biogenesis in proliferating cells, but their expression levels have not been systematically compared with those of ribosomal proteins. We analyzed Human Protein Atlas RNA-sequencing data from 1132 cancer cell lines, comparing 280 ribosome biogenesis-related genes with 88 ribosomal protein (RP) genes. RP genes were generally highly expressed, whereas expression of ribosome biogenesis-related genes varied widely. NPM1 was the most highly expressed gene in the latter group, with expression comparable to that of many RP genes. To investigate how NPM1 expression is maintained, we analyzed its promoter using reporter assays and identified a proximal sequence that supports promoter activity. A dominant-negative nuclear respiratory factor 1 (NRF1) mutant reduced reporter activity when its putative target sequence was present. NRF1 knockdown decreased endogenous NPM1 mRNA level, and chromatin immunoprecipitation (ChIP) detected NRF1 at the proximal NPM1 promoter. Analysis of public NRF1 ChIP-sequence data revealed promoter-proximal occupancy at a subset of ribosome biogenesis-related genes, including NPM1, FBL, and DKC1. NRF1 binding to the FBL and DKC1 promoters was also confirmed by ChIP assay, and expression of both genes decreased upon NRF1 knockdown. These findings identify NRF1 as a contributor to the expression of a subset of ribosome biogenesis-related genes.
    Keywords:  NPM1; NRF1; Ribosomal protein; Ribosome biogenesis; Transcription regulation
    DOI:  https://doi.org/10.1016/j.bbrc.2026.154806
  42. Epigenomes. 2026 Oct 04. pii: 63. [Epub ahead of print]10(4):
      Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide. Emerging evidence has established N6-methyladenosine (m6A) RNA methylation as a key epitranscriptomic mechanism underlying hepatocarcinogenesis. Methyltransferase-like 3 (METTL3), the catalytic core of the m6A methyltransferase complex (MTC), forms a heterodimer with METTL14 and cooperates with auxiliary components of the MTC to deposit m6A modifications that modulate mRNA stability, splicing, nuclear export, and translation. In this review, we comprehensively summarize the current understanding of METTL3 biology in HCC, focusing on its structure, assembly within the MTC, regulation of coding and non-coding RNAs, and its roles in driving key oncogenic signaling cascades, such as JAK/STAT3, PI3K/AKT/mTOR, Wnt/β-catenin, Hippo/YAP, Notch, Hedgehog, and epithelial-mesenchymal transition. In addition, we discussed how METTL3 remodels the tumor immune microenvironment (TIME) by regulating immune responses and metabolic pathways promoting immune evasion and therapy resistance. Therapeutic strategies targeting METTL3-including small-molecule inhibitors, CRISPR-Cas9 approaches, combination immunotherapy, and tumor-selective delivery systems-are discussed together with the challenges that continue to limit clinical translation. Collectively, these findings position METTL3 as a central epitranscriptomic regulator of HCC progression; however, further mechanistic and clinical validation remains necessary to establish its utility as a therapeutic target and prognostic biomarker.
    Keywords:  METTL3; N6-methyladenosine; epitranscriptomics; hepatocellular carcinoma; tumor microenvironment
    DOI:  https://doi.org/10.3390/epigenomes10040063
  43. Int J Mol Sci. 2026 Oct 16. pii: 9211. [Epub ahead of print]27(20):
      Oxidized graphene quantum dots (o-GQDs) alter viability and cell-cycle progression in breast cancer cells, yet the cellular programs underlying these effects remain incompletely defined. We exposed MCF-7 cells to 10 mg/L o-GQD for 72 h and integrated RNA sequencing with quantitative protein-marker, ROS, antioxidant-intervention, proteasome-inhibition, and puromycin-labeling analyses from independent experiments. Transcriptomic analyses showed significant negative enrichment of proliferative and cell-cycle programs (E2F Targets, G2M Checkpoint, MYC Targets V1), with complementary KEGG/Reactome evidence of attenuated estrogen-associated programs. Quantitative Western blotting showed dose-dependent reductions in ERα (to 41.36 ± 13.73% at 10 mg/L), p-RB (to 8.31 ± 10.39%), and Survivin (to 23.97 ± 19.01%), with p-ERK/ERK attenuation and marked γ-H2AX accumulation (345.21 ± 161.39%). The ROS-positive fraction rose from 6.86% to 30.46%; antioxidant co-treatment failed to rescue the phenotype and MG132 did not consistently restore protein markers, arguing against oxidative stress or proteasomal degradation as standalone drivers. Reduced puromycin labeling added a protein-homeostasis readout consistent with reduced nascent protein synthesis. BT-474 and MDA-MB-231 cells showed weaker or different marker responses. Together, these findings define a coordinated MCF-7 response spanning estrogen-associated and cell-cycle programs, survival markers, protein homeostasis, and cell fate.
    Keywords:  MCF-7; PI3K-AKT-FoxO; breast cancer; estrogen receptor; nascent protein synthesis; oxidative stress; oxidized graphene quantum dots
    DOI:  https://doi.org/10.3390/ijms27209211
  44. Mech Ageing Dev. 2026 Oct 29. pii: S0047-6374(26)00120-X. [Epub ahead of print] 112268
      Heat shock factors (HSF1 and HSF2) critically maintain proteostasis under stress, yet their activation across the continuum of rising temperatures is incompletely understood. Furthermore, how age impacts thermally driven rheostatic changes in stress responses is not fully elucidated. Here, we investigate how different temperature levels impact HSF1 and HSF2 in Jurkat T cells and splenocytes from young and aged mice. Using Western blotting, EMSA, RT-qPCR, immunofluorescence, and co-immunoprecipitation, we examined heat shock response changes across a range of thermal conditions. Unlike most cell types that require 42°C for HSF1 activation, Jurkat cells maximally responded at 41°C and splenocytes at 40°C. Optimal HSF1 activation coincided with maximal nuclear translocation, Ser326 phosphorylation, SIRT1 protein levels, and HSP RNA levels. By contrast, HSF2 nuclear translocation required a higher temperature (42°C) than HSF1. Age reduced HSF1 protein levels and nuclear translocation during thermal stress, while HSF2 protein levels were significantly elevated. These findings reveal distinct temperature-sensitive patterns of HSF1 and HSF2 activation of immunocytes during heat stress and identify age-associated alterations in this response.
    Keywords:  Aging; HSF1; HSF2; HSP; Heat shock
    DOI:  https://doi.org/10.1016/j.mad.2026.112268
  45. Int J Mol Sci. 2026 Oct 21. pii: 9368. [Epub ahead of print]27(20):
      Ubiquitin-specific protease 30 (USP30) is a mitochondrial outer membrane-associated deubiquitinase best known for antagonizing PTEN-induced kinase 1 (PINK1)/Parkin-dependent ubiquitination and suppressing mitophagy. This established role has linked USP30 to mitochondrial quality control and neurodegenerative diseases. However, emerging studies in cancer have expanded the biological scope of USP30, revealing functions that cannot be explained by mitophagy regulation alone. USP30 regulates diverse cancer-associated substrates through deubiquitination, thereby affecting protein abundance, subcellular localization, protein interactions, and downstream transcriptional programs. These substrate-dependent effects influence mitochondrial dynamics, lipid synthesis, glucose and amino acid metabolism, redox homeostasis, apoptosis, ferroptosis, epithelial-mesenchymal transition, cancer stemness, T-cell exhaustion, and therapy resistance. Although most studies indicate tumor-promoting roles of USP30 in hepatocellular carcinoma, breast cancer, colorectal cancer, oral squamous cell carcinoma, ovarian cancer, bladder cancer, prostate cancer, and leukemia models, context-dependent tumor-restraining activities have also been reported. In this Review, we examine cancer-associated functions of USP30 that extend beyond its established role in PINK1/Parkin-dependent mitophagy, discuss the spatial and substrate-dependent mechanisms underlying these activities, and highlight opportunities and challenges for therapeutic targeting.
    Keywords:  USP30; cancer; cancer metabolism; context-dependent regulation; deubiquitinase; mitochondrial quality control; mitophagy; therapy resistance
    DOI:  https://doi.org/10.3390/ijms27209368
  46. Pharmacol Res. 2026 Oct 29. pii: S1043-6618(26)01635-X. [Epub ahead of print] 109720
      Endoplasmic reticulum (ER) stress activates a dynamic signaling network known as the unfolded protein response (UPR), which aims to reestablish cellular protein homeostasis and promote cell survival during stress. Dysregulated UPR signaling has been increasingly implicated in neurodegenerative diseases, many of which are characterized by tau hyperphosphorylation, misfolding, aggregation, and impaired clearance, contributing to neuronal dysfunction and degeneration. Genetic variations in UPR pathway components and their downstream effectors may influence the magnitude, duration, and cellular consequences of ER stress responses, thereby shaping disease susceptibility, progression, and therapeutic response. This review examines genetic variation within the UPR pathway and its relevance to the pathophysiology of tau-associated neurodegenerative diseases. By integrating evidence from genetic, cellular, and disease-model studies, we highlight how UPR dysregulation represents an important mechanistic interface linking genetic susceptibility with cellular stress responses, proteostasis disruption, and tau pathology. The article further explores UPR-focused therapeutic approaches, emphasizing how understanding genetic variation may provide insights into disease mechanisms and identify potential therapeutic targets. Building on these findings, we propose a framework in which UPR dysregulation is viewed not merely as a passive cellular response to neurodegeneration, but as a potential mechanistic determinant linking genetic risk to altered stress adaptation, proteostatic imbalance, and tau pathology. Within this framework, genetic variation in UPR components may contribute to distinct disease-relevant UPR states and influence therapeutic responsiveness. Integrating genetic variation with functional UPR signatures and treatment response may ultimately reveal disease-relevant therapeutic opportunities and inform the development of more precise UPR-targeted strategies for tau-associated neurodegenerative diseases.
    Keywords:  ATF6; Endoplasmic reticulum stress; IRE1; Neurodegenerative diseases; PERK; Tau pathology; Therapeutic strategies; Unfolded protein response
    DOI:  https://doi.org/10.1016/j.phrs.2026.109720
  47. Int J Biol Macromol. 2026 Oct 28. pii: S0141-8130(26)05000-2. [Epub ahead of print] 155048
      Pancreatic ductal adenocarcinoma (PDAC) remains a major public health challenge worldwide, marked by difficulties in early diagnosis and a dismal prognosis. The overtly immunosuppressive nature of its tumor microenvironment (TME) renders PDAC largely refractory to existing immunotherapies. Tumor-associated macrophages, the predominant immune infiltrate in the TME, are pivotal in facilitating immune escape. While m6A RNA methylation, the most abundant eukaryotic post-transcriptional modification, is known to contribute to PDAC progression, its specific function in mediating tumor-immune interactions has yet to be fully elucidated. We identify RBM15, a core m6A methyltransferase component, as a key regulator of macrophage phagocytosis in PDAC. RBM15 is notably upregulated in PDAC tissues and is associated with immunosuppressive macrophage infiltration and poor prognosis. Mechanistically, RBM15 binds CSF2 mRNA and enhances its stability in an m6A-dependent manner, thereby increasing CSF2 secretion from pancreatic cancer cells. Tumor-derived CSF2 then activates STAT3 signaling in macrophages, thereby impairing their phagocytic function. In vivo orthotopic models further demonstrate that RBM15 promotes PDAC progression and is accompanied by activation of the CSF2/STAT3 axis and increased immunosuppressive macrophage infiltration. Collectively, our findings reveal a novel non-cell-autonomous mechanism whereby tumor cell m6A modification regulates macrophage function, and provide experimental evidence supporting a potential role of the RBM15/CSF2/STAT3 axis in the immunosuppressive remodeling of the PDAC microenvironment.
    Keywords:  Macrophage phagocytosis; Pancreatic cancer; RBM15; Tumor microenvironment; m6A methylation
    DOI:  https://doi.org/10.1016/j.ijbiomac.2026.155048
  48. Nucleic Acids Res. 2026 Oct 24. pii: gkag1022. [Epub ahead of print]54(20):
      FET family proteins (FUS, EWSR1, and TAF15) have garnered significant attention due to their involvement in oncogenic fusions and mutations in various cancers and neurodegenerative disorders. Although these highly conserved RNA-binding proteins are widely described as multifunctional regulators of gene expression, their precise molecular functions remain incompletely understood. Here, we uncover a previously unrecognized role for EWSR1 as a selective translational repressor in cancer cells. EWSR1 specifically targets mRNAs involved in lipid metabolism and endoplasmic reticulum (ER) homeostasis. Loss of EWSR1 disrupts ER morphology and impairs activation of the unfolded protein response of the ER (UPRER). Mechanistically, EWSR1 represses translation upon association with target mRNAs, and its conserved region spanning two arginine-glycine-glycine (RGG) boxes contributes to association with the 40S ribosomal subunit. These findings define a novel role for EWSR1 in post-transcriptional gene regulation and suggest that perturbations in its translational activity may underlie the pathogenesis of FET-associated diseases.
    DOI:  https://doi.org/10.1093/nar/gkag1022
  49. Genes (Basel). 2026 Oct 03. pii: 1228. [Epub ahead of print]17(10):
       BACKGROUND: N6-methyladenosine (m6A) is the most abundant mRNA internal modification in eukaryotes and regulates inflammatory and regenerative processes. Many studies relate the dysregulation of m6A-related pathways to periodontal inflammation, imbalance in cell homeostasis, impaired tissue regeneration, and remodeling of the alveolar bone. However, the mechanisms of the relationship between the m6A pathway and periodontitis have not been elucidated clearly yet.
    OBJECTIVE: The objective of the current narrative review is to integrate the information related to the role of m6A RNA modification in the pathogenesis of periodontitis by focusing on inflammatory signaling, osteoimmune regulation, periodontal cell activity, bone remodeling, and its possible applications as a diagnosis and treatment approach.
    METHODS: A literature search was conducted in PubMed to identify original research studies investigating the role of m6A RNA methylation and its regulators in periodontitis and periodontal tissues/cells. Out of 49 publications reviewed, 34 original research articles fulfilled the predetermined inclusion criteria.
    RESULTS: The current literature suggests that N6-methyladenosine (m6A) modification is involved in various interconnected biological processes contributing to the development of periodontitis, including inflammatory responses, inflammasome activation and pyroptosis, osteoimmune reactions by macrophages, osteogenic differentiation, osteoclast formation, cellular senescence, and periodontal cells homeostasis. METTL3 has been reported to be the most widely investigated regulator, but its roles are not consistently harmful or beneficial. Depending on the RNA target, cellular environment, and state of inflammation, some of the m6A-associated pathways have been linked to periodontal inflammation and alveolar bone resorption, while others were linked to osteogenesis and regeneration. Several studies have highlighted the possibility of therapeutic interference in pathways leading to the formation of m6A, while human transcriptomic and gingival/salivary studies suggested that m6A could be used as a biomarker.
    CONCLUSIONS: The m6A modification of RNA is an emerging epitranscriptomic effect relating periodontal inflammation, immune responses, cellular differentiation, and bone remodeling. Even though target molecules and signaling pathways have been experimentally identified as points of potential therapeutic interference, the available evidence remains predominantly preclinical. Future work is expected to validate the diagnostic and therapeutic involvement of the m6A modification in periodontitis.
    Keywords:  ALKBH5; FTO; METTL14; METTL3; N6-methyladenosine; alveolar bone loss; epitranscriptomics; inflammation; m6A; osteogenesis; periodontal ligament stem cells; periodontitis
    DOI:  https://doi.org/10.3390/genes17101228
  50. Cells. 2026 Oct 14. pii: 1864. [Epub ahead of print]15(20):
      The small molecule simufilam, also called PTI-125, has been reported to reduce cell overgrowth and seizure activity in a mouse model of tuberous sclerosis complex (TSC). TSC is a multisystem developmental disorder caused by mutations in TSC1 or TSC2, resulting in mTOR complex 1 (mTORC1) hyperactivity and downstream cellular changes that contribute to focal malformations of the developing cortex and abnormal growth throughout the body. Here, to better understand the role of simufilam at the cellular level, we investigated the impact of simufilam on the proteome of TSC2 knockout (KO) HEK293T cells in vitro. We first validated that TSC2 KO cells displayed increased mTORC1 activity and elevated expression of the stress-associated marker ATF4 compared with TSC2 wild-type (WT) cells. Simufilam reduced ATF4 expression but did not attenuate mTORC1 activity. Next, using LC-MS/MS in TSC2 KO cells, we identified 514 differentially abundant proteins following simufilam treatment. Pathway and protein-protein interaction analyses revealed coordinated changes in mitochondrial translation and bioenergetic pathways, including mitochondrial ribosomal proteins and respiratory-chain-associated proteins, as well as pathways related to preribosome biogenesis, rRNA processing, RNA metabolism, and to some extent RHO GTPase-actin signaling, and chromatin/transcriptional regulation. Selected proteins from these pathways, including MRPS30, MRPL43, MRPL16, ALDH1L2, NDUFA6, and RBM19, were further examined by immunoblotting and found to be altered by simufilam treatment. Functionally, simufilam restored mitochondrial membrane potential in TSC2 KO cells. Overall, these findings support a potential mTORC1-independent role for simufilam in attenuating cellular stress and regulating mitochondrial function in TSC.
    Keywords:  TSC1; TSC2; mTOR; mitochondria; simufilam; tuberous sclerosis complex
    DOI:  https://doi.org/10.3390/cells15201864
  51. Biochem Cell Biol. 2026 Oct 28.
      Ribonucleoprotein (RNP) granules are biomolecular condensates composed of RNAs and RNA-binding proteins that help organize gene expression, small RNA pathways, and genome surveillance. Recent studies have shown that germline RNP granules in Caenorhabditis elegans are not uniform structures; instead, they comprise multiple functionally specialized yet spatially coordinated subcompartments. Growing evidence indicates that this higher-order organization is crucial for RNA-mediated gene silencing and the transgenerational inheritance of epigenetic information. Here, we summarize recent advances in the composition, spatial organization, and functional specialization of C. elegans germline RNP granules, with an emphasis on how compartmentalization coordinates small RNA pathways and supports the maintenance and inheritance of gene silencing. We also highlight unresolved questions and emerging challenges in the field to provide an updated framework for understanding how membraneless organelles regulate RNA metabolism and epigenetic inheritance.
    DOI:  https://doi.org/10.1139/bcb-2026-0206
  52. Epigenomes. 2026 Oct 05. pii: 64. [Epub ahead of print]10(4):
      Epitranscriptomic drug discovery has mostly targeted the catalytic "writers" (METTL3/METTL14) and "erasers" (FTO, ALKBH5) that deposit and remove N6-methyladenosine (m6A). That strategy just hit clinical validation: STC-15, a METTL3 inhibitor, has measurable anti-tumor activity from a first-in-human oncology trial, but the same structural features that made these enzymes attractive also limit them. Inhibition shifts m6A stoichiometry globally, while an m6A mark's functional impact depends almost entirely on cellular context. YTHDF family reader proteins offer another angle. Their low-complexity domains drive liquid-liquid phase separation (LLPS). m6A binding stimulates this condensation across YTHDF paralogs-a property that matters for therapeutic selectivity. We propose a Phase Transition Threshold model in which YTHDF2's condensation concentration decides whether synaptic mRNAs are degraded or maintained in translation-competent, FMRP-associated states. Recent evidence has established YTHDF2 synaptic localization, FMRP condensate formation in neurons, and functional antagonism between the two proteins. The central unresolved question is whether condensation in living cells is nucleation-driven rather than bulk-concentration-driven. If so, concentration-centered pharmacology misses the point. We present falsifiable predictions and a staged experimental program. A more fundamental risk is that YTHDF2-mediated decay may not require condensate formation at all. If that is the case, the therapeutic premise of this Perspective collapses.
    Keywords:  FMRP; YTHDF2; condensate pharmacology; epitranscriptomic drug discovery; liquid–liquid phase separation; m6A RNA methylation; synaptic plasticity
    DOI:  https://doi.org/10.3390/epigenomes10040064
  53. J Am Chem Soc. 2026 Oct 28. 148(42): 45830-45839
      Cell-free autonomous biogenesis of ribosomes is important for the bottom-up assembly of an artificial cell and for engineering of functional ribosomes with novel activities. The challenge lies in establishing conditions for a single-step multicomponent synthesis and assembly process in a minimal transcription-translation reaction. We previously reported autonomous synthesis and assembly of a bacterial small ribosomal subunit, but the assembly pathway of the large subunit is more complex with dozens of proteins that bind, fold, and chemically modify its ∼3000-base-long rRNA (rRNA). Here, we cosynthesized all the large subunit components including 33 ribosomal proteins (r-proteins) and 2 rRNAs from DNA brushes and followed the dynamics of assembly coupled to synthesis in real time using total internal reflection fluorescence microscopy. A systematic screen of the binding of each of the ribosomal proteins to the 23S rRNA revealed an assembly pattern indicative of early intermediates. The addition of genes coding for six rRNA assembly factors facilitated binding of late assembly ribosomal proteins, supporting formation of late-stage intermediates even in the absence of rRNA modifications. We established a scenario for the large subunit biogenesis via macromolecular colocalization that may aid in the identification and characterization of additional genes required for achieving complete functional ribosome self-regeneration in a minimal system.
    DOI:  https://doi.org/10.1021/jacs.6c13587
  54. Rinsho Ketsueki. 2026 ;67(9): 1172-1181
      RNA helicases comprise a large family of enzymes that act on RNA or RNA-protein complexes to remodel their structures. More than 70 RNA helicases have been identified in humans, and they are involved in nearly all cellular processes that require dynamic RNA structural rearrangements. A subset of myeloid neoplasms is associated with germline predisposition, among which DDX41, a representative member of the DEAD-box RNA helicase family, is one of the most important causative genes. Although one of the major cellular functions of DDX41 is thought to be pre-mRNA splicing, it is unlikely to directly determine splice site selection. Rather, recent studies suggest that DDX41 plays an integrative regulatory role in transcription and RNA splicing by preventing the accumulation of specific nucleic acid structures known as R-loops. This review summarizes the physiological roles of RNA helicases, including DDX41, and discusses their relevance to human disease, with a particular focus on hematopoietic neoplasms.
    Keywords:  DDX41; Myeloid neoplasms; R-loop; RNA helicase
    DOI:  https://doi.org/10.11406/rinketsu.67.1172
  55. J Biochem. 2026 Oct 31. pii: mvag077. [Epub ahead of print]
      Ribosomal RNA maturation requires nucleases that recognize appropriate precursors and cleave them at defined stages of ribosome assembly. How these activities are organized in archaea remains elusive. Kawai and colleagues determined the crystal structure of the archaeal ribonuclease FAU-1, revealing a homotrimer with peripheral RNA-binding domains and a central assembly formed by its C-terminal domains. The structure identifies similarities to the RNA-recognition region of bacterial ribonuclease (RNase) E while exposing substantial differences in overall architecture. Subsequent work assigned FAU-1 to the RNase W family and demonstrated a catalytic role for its C-terminal domain. Together, these studies illustrate how related RNA-recognition elements can operate within distinct nuclease architectures. They also raise questions about the relationship between oligomerization, substrate selection and catalytic activation. Resolving these questions will require analysis of physiological RNA substrates and their associated proteins, connecting the structures of individual processing enzymes to the assembly of functional ribosomes.
    Keywords:  FAU-1; RNase W; archaea; rRNA processing; ribosome biogenesis
    DOI:  https://doi.org/10.1093/jb/mvag077
  56. Pharmaceutics. 2026 Oct 07. pii: 1266. [Epub ahead of print]18(10):
      Aging is associated with a progressive loss of proteostasis and increased susceptibility to neurodegenerative and metabolic disorders. Among the molecular mechanisms implicated in these processes, protein persulfidation, a hydrogen sulfide (H2S)-mediated cysteine modification, has emerged as a critical regulator of protein function and redox homeostasis. Recent studies demonstrate that aging is accompanied by a decline in persulfidation and a concomitant increase in irreversible cysteine hyperoxidation, leading to protein dysfunction and aggregation. Beyond its established role in protecting proteins from oxidative damage, persulfidation has recently been shown to regulate biomolecular condensation and liquid-liquid phase separation, suppressing the formation of pathological protein assemblies linked to aging and neurodegenerative diseases. Moreover, pharmacological approaches that enhance persulfidation, including stimulation of endogenous H2S production and treatment with ergothioneine, improve metabolic resilience, increase NAD+ levels, and promote healthspan in experimental models. In this review, we discuss emerging evidence linking loss of persulfidation to protein aggregation, biomolecular condensates, and age-related functional decline, and highlight therapeutic strategies aimed at restoring persulfidation as a promising avenue for healthy aging and disease intervention.
    Keywords:  aging; biomolecular condensates; cysteine hyperoxidation; cysteine sulfonylation-mediated aggregation; ergothioneine; healthspan; hydrogen sulfide; liquid–liquid phase separation; neurodegeneration; oxidative stress; persulfidation; protein aggregation
    DOI:  https://doi.org/10.3390/pharmaceutics18101266
  57. bioRxiv. 2026 Aug 31. pii: 2026.08.26.747275. [Epub ahead of print]
      The proportional scaling between nuclear and cell size was first described more than 150 years ago and is among the most conserved features of cellular organization. Yet the mechanisms that establish this scaling and its physiological significance have remained unresolved. Here, we address both questions by combining image-enabled cell sorting with genome-wide CRISPR screening, transcriptomics and functional analyses. We identify more than 180 regulators of the nuclear-to-cell ratio and show that distinct classes of genes independently control nuclear and cell size. RNA metabolism predominantly regulates nuclear size, whereas protein synthesis and degradation primarily regulate cell size. This supports a model in which differences in macromolecular partitioning between the nucleus and cytoplasm contribute to osmotic regulation of nuclear size together with mechanical constraints imposed by chromatin, the cytoskeleton, and the nuclear envelope. Changes in nuclear size cause widespread transcriptional remodeling that is independent of changes in cell size. Cells with smaller nuclei exhibit reduced PRC2-dependent H3K27 trimethylation, activation of developmental gene-expression programmes and repression of cell-cycle genes. Consistent with these changes, mouse embryonic stem cells with smaller nuclei show an increased propensity to exit pluripotency and initiate differentiation in response to retinoic acid. Together, our findings provide a mechanistic framework for nuclear size scaling and establish nuclear size as a physical regulator of gene expression and cell-state transitions, linking cellular architecture to cell fate.
    DOI:  https://doi.org/10.64898/2026.08.26.747275
  58. Int J Mol Sci. 2026 Oct 16. pii: 9199. [Epub ahead of print]27(20):
      Somitogenesis is orchestrated by the segmentation clock, a highly conserved developmental oscillator that generates periodic gene expression waves to establish precise somite boundaries along the vertebrate body axis. While transcriptional feedback circuits and signaling gradients are recognized as central determinants of clock dynamics, accumulating evidence indicates that RNA-centered regulation provides an important layer of temporal control. We therefore focus primarily on established RNA-regulatory processes, including nascent RNA synthesis, pre-mRNA processing, transcript stability and degradation, and translational control, and examine how these processes interact with protein turnover and intercellular signaling to shape oscillation period, amplitude, and synchronization. Because the molecular implementation of the clock differs among vertebrates, we distinguish species-specific systems throughout: mouse studies primarily define hairy and enhancer of split 1 (Hes) 7/lunatic fringe (Lfng)/Delta-like canonical Notch ligand (Dll) 1 dynamics, zebrafish studies define Hes-related bHLH transcriptional repressor (her) 1/her7/deltaC/deltaD dynamics, chick studies established cyclic c-hairy1/lfng expression, and human HES7/LFNG dynamics are examined mainly in stem-cell-derived presomitic mesoderm (PSM) models. These mechanisms are used to formulate experimentally testable hypotheses about phase-dependent RNA stability, translation, and developmental state transitions. Together, the segmentation clock provides a quantitative framework for distinguishing established RNA-protein mechanisms from emerging RNA-regulatory hypotheses and for understanding how their disruption may contribute to congenital vertebral disorders.
    Keywords:  RNA modification; RNA processing; epitranscriptomics; mRNA decay; post-transcriptional regulation; segmentation clock; somitogenesis; translational control
    DOI:  https://doi.org/10.3390/ijms27209199
  59. Neuropsychiatr Dis Treat. 2026 ;22 624820
      Depressive disorders (DDs) are heterogeneous neuropsychiatric conditions arising from complex interactions among genetic susceptibility, environmental stress, metabolic disturbances, neuroinflammation and impaired neuroplasticity. Increasing evidence suggests that metabolic-epigenetic crosstalk contributes to DD pathophysiology. Protein acylation, which couples metabolite-derived acyl groups to histone and non-histone proteins, provides a potential molecular interface between cellular metabolism and the regulation of gene expression, protein function and intracellular signaling. The present review summarizes current evidence implicating major acylation modifications, including acetylation, crotonylation, succinylation, β-hydroxybutyrylation, lactylation, palmitoylation and myristoylation, in DDs. The current study discusses how dysregulated acylation may influence neuroplasticity and neuroimmune responses, and examines the roles of key regulatory enzymes in DDs. Furthermore, the present review summarizes that deacylases HDACs play a central, pivotal regulatory role in the pathological progression of DDs. Finally, it discusses emerging experimental and therapeutic strategies for DDs, including spatially resolved acyl-proteomics, single-cell analysis and targeted modulation of acylation-regulating enzymes. These approaches may clarify the cell-type- and brain-region-specific functions of acylation, and may facilitate the development of mechanism-based biomarkers and personalized therapeutic interventions for biologically defined subgroups of DDs. However, clinical translation remains challenging because causal evidence is still limited, acylation effects are highly cell- and context-specific, peripheral biomarkers may not reliably reflect brain alterations, and pharmacological targeting of acylation enzymes may be constrained by limited selectivity and off-target effects. Addressing these challenges may clarify the mechanistic significance of acylation in DDs and support the development of more precise biomarkers and mechanism-informed therapeutic strategies.
    Keywords:  acyl-modification; depressive disorder; histone deacetylases; sirtuins
    DOI:  https://doi.org/10.2147/NDT.S624820
  60. Chem Biol Drug Des. 2026 Oct;pii: e70421. [Epub ahead of print]108(4):
      m6A modification regulates the functions of long non-coding RNAs (lncRNAs) through diverse mechanisms. However, whether the lncRNA MALAT1 regulates the progression of non-small cell lung cancer (NSCLC) through targeted regulation of METTL3 remains unclear, and the underlying molecular mechanisms have yet to be elucidated. This study aimed to investigate the role of MALAT1 in NSCLC progression by targeting and regulating METTL3. NCI-H226 NSCLC cells were used as experimental models. RIP and FISH assays were performed to validate the physical interaction between MALAT1 and METTL3. Cells were co-transfected with si-MALAT1 and METTL3 overexpression constructs for rescue experiments. FISH was used to determine the subcellular localization of MALAT1. Apoptotic activity was quantified by flow cytometry, while cell proliferation was assessed using the EdU incorporation assay. The Transwell assay was performed to evaluate cell migration, and the EpiQuik m6A RNA Methylation Quantification Kit was used to detect cellular m6A methylation levels. Xenograft mouse models were established to evaluate in vivo tumor growth, and clinical NSCLC specimens were analyzed to investigate the clinical correlation among METTL3, INPP5B, and LRIG2. The experimental results showed that MALAT1 was predominantly localized in the nucleus and interacted with METTL3. Following si-MALAT1 treatment, cell proliferation and migration were decreased, although no significant change was observed in colony formation ability. Furthermore, apoptosis was increased, accompanied by cell cycle arrest at the G0/G1 phase. After MALAT1 interference, transfection with a METTL3 overexpression vector reversed these malignant phenotypes, reduced apoptosis, induced S-phase accumulation, and significantly downregulated the tumor suppressor gene INPP5B while upregulating the oncoprotein LRIG2. Consistently, in vivo xenograft assays demonstrated that MALAT1 knockdown suppressed tumor growth, which was rescued by METTL3 overexpression. Clinical sample analysis further supported the correlation among METTL3, INPP5B, and LRIG2 in NSCLC tissues. These findings substantiate the regulatory role of MALAT1-mediated METTL3 modulation in NSCLC progression through the INPP5B/LRIG2 signaling axis.
    Keywords:  INPP5B/LRIG2 signaling pathway; METTL3; NSCLC; lncRNA MALAT1; targeted binding
    DOI:  https://doi.org/10.1111/cbdd.70421
  61. J Inflamm Res. 2026 ;19 621928
      Autophagy is a lysosome-dependent stress-response pathway that maintains cellular homeostasis through the degradation and recycling of damaged proteins, dysfunctional organelles, and other cytoplasmic components. In the lung, autophagy is closely linked to inflammatory signaling, mitochondrial quality control, oxidative stress, epithelial barrier integrity, and immune-cell activation. These processes are highly relevant to respiratory diseases and perioperative pulmonary injury because hypoxia, mechanical stretch, ischemia-reperfusion, hyperoxia, infection-related stress, and systemic inflammation may alter autophagic flux. Context-dependent autophagic responses may protect lung tissue by limiting mitochondrial damage and excessive inflammatory activation, whereas impaired pathway completion may promote persistent reactive oxygen species production, endothelial and epithelial injury, fibroblast activation, and maladaptive tissue remodeling. In cardiothoracic surgery, lung resection, one-lung ventilation, cardiopulmonary bypass, and transplantation are clinically relevant settings in which autophagy-inflammation crosstalk may affect postoperative pulmonary complications and organ recovery. Here, we present a perioperative, flux-centered framework that distinguishes stress-induced initiation from autophagosome-lysosome fusion and lysosomal degradation. The framework integrates AMPK-mTORC1-ULK1 signaling with TFEB-dependent lysosomal biogenesis, FOXO transcriptional control, selective mitophagy, and downstream NLRP3, NF-κB, and cytokine responses. Human studies demonstrate biological heterogeneity but rarely measure dynamic flux; LC3-II, p62/SQSTM1, Beclin-1, or ATG abundance alone cannot establish pathway completion. Translational studies should use serial, compartment-aware autophagy-lysosome, mitochondrial-injury, and inflammatory readouts linked to standardized pulmonary outcomes. Major priorities include cell-resolved perioperative phenotyping, harmonized reporting of flux uncertainty, prospective one-lung-ventilation and cardiopulmonary-bypass cohorts, and short, mechanism-matched intervention studies with explicit safety endpoints.
    Keywords:  autophagic flux; cardiopulmonary bypass; lysosomal degradation; one-lung ventilation; perioperative lung injury
    DOI:  https://doi.org/10.2147/JIR.S621928
  62. Nucleic Acids Res. 2026 Oct 24. pii: gkag1005. [Epub ahead of print]54(20):
      Bacterial ribosomal RNA (rRNA) methylations are important for accurate translation. Four distinct methylations incorporated by RsmE, RsmF, and RsmH/ RsmI form a cluster of three modified 16S rRNA nucleotides (m3U1498, m5C1407, and m4Cm1402) surrounding the decoding center of the 30S subunit. Given their common substrate requirement of a late-stage intermediate 30S subunit, these enzymes likely act contemporaneously during subunit biogenesis, but whether there exists a required modification order is unknown. Here, using hypomethylated 30S subunits obtained from a collection of rsmH/I/E/F-deleted Escherichia coli strains, we identify RsmF activity to be highly dependent on prior modification of h44 both in vitro and in E. coli. RsmF activity on hypomethylated 30S subunits could be partially rescued by prior in vitro methylation using RsmE and RsmH, indicating that incorporation of these methyl groups directly shapes h44 for recognition by RsmF. RNA structure probing using selective 2'-hydroxyl acylation analyzed by primer extension and mutational profiling and molecular dynamics simulations reveal specific alterations in 16S rRNA structure and dynamics in the absence of the m4C1402 (RsmH) and m3U1498 (RsmE) modifications that likely restrict RsmF action. These studies thus uncover a previously unappreciated "order of operations" for 16S rRNA modification during ribosome biogenesis with important implications for studies on the collective functions of these modifications.
    DOI:  https://doi.org/10.1093/nar/gkag1005
  63. Front Immunol. 2026 ;17 1976931
      Acute pancreatitis (AP) progression involves both the initiating acinar injury and immune responses that sustain or contain subsequent damage. This review integrates evidence on metabolic regulation in macrophages and neutrophils to examine its links to inflammatory effectors, clearance, and tissue protection. Glycolytic regulation can support inflammatory activation, while non-AP neutrophil studies show how substrate allocation supports oxidant production and neutrophil extracellular trap (NET) release. Metabolite signaling also participates in macrophage efferocytosis, repair-associated responses, and tissue antioxidant defense. Contrasting lactate effects in acinar injury and macrophage repair indicate that metabolic changes must be interpreted through their effects on particular cells and functions. We propose an integrated amplification-braking framework that connects metabolically supported inflammatory effectors to continued generation of injury-derived stimuli, and clearance, antioxidant, and repair functions to damage containment. These functions can coexist without receiving equivalent metabolic support, and protective braking is distinct from generalized immunosuppression. Evidence differs across cells and experimental systems; metabolic regulation of inflammatory activation does not by itself establish metabolic control of NET-mediated injury in AP. The framework provides a basis for evaluating whether metabolic interventions can limit damaging activity while preserving protective functions, but it is not a validated clinical model. Pairing metabolic changes with specific cellular functions and subsequent injury is central to testing these relationships.
    Keywords:  acute pancreatitis; immunometabolism; macrophage; metabolic reprogramming; metabolic stress; neutrophil
    DOI:  https://doi.org/10.3389/fimmu.2026.1976931
  64. Front Bioinform. 2026 ;6 1878616
      Glioblastoma (GBM) is a major public health issue with increased prevalence and incidence worldwide. The therapeutic strategy is based on surgical resection, followed by chemotherapy and radiotherapy. However, therapeutic failure is increasingly recognized as driven by the intricate characteristics of the tumor microenvironment (TME). Stress granules (SGs) are structures that emerge in cells in response to stress. In GBM, these elements are implicated in tumor development and progression. Heterogeneous elements coalesce to form SGs, with RNA-binding proteins (RBPs) among them. DZIP3, DAZ-interacting zinc finger 3, is an understudied RBP in cancer, particularly with respect to its impact on TME remodeling. In the current study, we evaluate the prognostic value of DZIP3 using The Cancer Genome Atlas and the Chinese Glioma Genome Atlas as the validation cohort. Furthermore, we identified enriched pathways associated with upregulated genes linked to high DZIP3 expression. The correlation between these gene sets and DZIP3 was validated using a robustness assessment. We also identified the core hub miRNAs that target DZIP3 by using validated miRNA databases. Our results revealed that initially, high DZIP3 expression was associated with better survival in the TCGA cohort, but after adjustment for age, gender, transcription subtypes, IDH mutation status, MGMT promoter methylation status, and Karnofsky performance score, the prognostic utility of DZIP3 did not persist. Similar results were observed in the CGGA cohort. Of the 30 enriched pathways obtained, only 7 retained independent association: the cytoskeletal dynamics/intracellular transport gene set was the strongest correlate of DZIP3, followed by 4 mitochondrial modules (branched-chain amino acid metabolism, NAD biosynthesis, translation factors, and pyruvate metabolism), RNA granule/neurodegeneration gene set, and the nucleocytoplasmic transport gene set. The immune checkpoints, P-bodies, and malignant cell state gene sets were not independent of this signal. The cytoskeletal signal was replicated in the CGGA cohort and at single-cell resolution, with 9 core hub miRNAs targeting DZIP3, suspected to be a regulatory mechanism. Altogether, this study identifies the cytoskeletal module, 4 mitochondrial programs, RNA granule/neurodegeneration, and nucleocytoplasmic transport gene sets as the strongest correlates of DZIP3 expression in GBM, demonstrating that clinical prognostic value is distinct from transcriptional reproducibility.
    Keywords:  DAZ interacting zinc finger 3; RNA-binding protein; glioblastoma; immune microenvironment; mitochondria; stress granules
    DOI:  https://doi.org/10.3389/fbinf.2026.1878616
  65. iScience. 2026 Nov 20. 29(11): 117945
      Zuo1 slows elongating ribosomes in response to nascent peptide misfolding, which in turn triggers co-translational decay of the transcript. The endogenous substrates of this pathway have remained undefined. Using RNA-sequencing and ribosome profiling of unstressed wild-type and zuo1Δ cells, we identified transcripts that accumulate in the absence of Zuo1, representing mRNAs normally downregulated by Zuo1-mediated surveillance. Proteins encoded by these transcripts displayed higher predicted disorder across multiple metrics, were enriched in basic residues, were depleted of proline residues, and were shorter in length. Ribosome profiling revealed that Zuo1 target transcripts exhibited higher ribosome occupancy in the presence of Zuo1, and the ratio of wild-type to zuo1Δ ribosome occupancy positively correlated with predicted disorder. These findings indicate that Zuo1 surveillance acts preferentially on transcripts encoding nascent chains that fail to acquire stable structure.
    Keywords:  Zuo1; disordered proteins; mRNA decay; protein misfolding; ribosome speed; translation elongation
    DOI:  https://doi.org/10.1016/j.isci.2026.117945
  66. Sci Adv. 2026 Oct 30. 12(44): eaej4259
      Hypoxia (decreased O2) induces physiological, metabolic, and behavioral changes. The major hypoxia response pathway is conserved from nematodes to mammals and is driven by activation of the HIF (hypoxia inducible factor) family of transcription factors. Despite a fundamental role of the HIF pathway in regulating cellular homeostasis in response to hypoxic stress, interactions between the HIF pathway and cellular quality control pathways are largely unknown. Using an unbiased genetic screen, we found that in C. elegans nonsense-mediated decay (NMD), an evolutionarily conserved mechanism of RNA surveillance, acts in parallel to HIF-1 to selectively enhance specific aspects of the response to HIF-1 activation, possibly through coregulation of a distinct subset of HIF-1-up-regulated genes. Our findings reveal a functional integration between oxygen sensing and RNA surveillance and establish NMD as a key regulator of specific aspects of the HIF-1-driven transcriptional program and physiological response.
    DOI:  https://doi.org/10.1126/sciadv.aej4259
  67. Epigenomes. 2026 Oct 03. pii: 62. [Epub ahead of print]10(4):
      N6-methyladenosine (m6A), the most prevalent internal modification in eukaryotic RNA, has emerged as a key epitranscriptomic regulator in the central nervous system, coordinating gene expression programs that govern neural development, synaptic plasticity, and neuronal adaptation throughout the lifespan. This review synthesizes emerging evidence that m6A dysregulation represents a shared epitranscriptomic mechanism linking neurodevelopmental and neurodegenerative disorders, highlighting a mechanistic convergence that bridges these traditionally distinct disease categories. Dysregulation of m6A-mediated control of neurogenesis, synaptic maturation, and dopaminergic development has been implicated in neurodevelopmental disorders, including autism spectrum disorder, attention-deficit/hyperactivity disorder, and intellectual disability. In neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, m6A dysregulation mediates multiple interconnected pathogenic processes, including neuroinflammation, mitochondrial dysfunction, tau hyperphosphorylation and aggregation, α-synuclein dysregulation, and impaired neuronal repair. Environmental stressors and metabolic perturbations modulate m6A modification patterns, suggesting that gene-environment interactions contribute to disease susceptibility through epitranscriptomic mechanisms. m6A modification functions as a dynamic molecular switch governing neural plasticity and circuit function across early development, adulthood, and aging, and its dysregulation predisposes individuals to neurological disease manifestation throughout the lifespan. Advances in cell-type-specific and circuit-resolved m6A profiling will deepen our understanding of m6A dysregulation and strengthen its translational potential as both a diagnostic biomarker and a therapeutic target in neurological diseases. Furthermore, we evaluate pharmacological and molecular strategies targeting m6A regulatory machinery, including the writers METTL3/METTL14, the erasers FTO/ALKBH5, and reader proteins, as promising therapeutic approaches to restore aberrant neuronal circuit function in neurodevelopmental and neurodegenerative disorders.
    Keywords:  m6A RNA modification; m6A erasers; m6A readers; m6A writers; neurodegenerative diseases; neurodevelopmental disorders
    DOI:  https://doi.org/10.3390/epigenomes10040062
  68. Mol Neurobiol. 2026 Oct 30. pii: 1004. [Epub ahead of print]63(1):
      Microglia-mediated inflammation is a major contributor to the development of Parkinson's disease (PD) and N6-Methyladenosine (m6A) has been implicated PD. Here, we explored whether m6A modification is associated with microglia-mediated inflammation using MPTP-treated mice and MPP+-exposed BV2 cells. AAV-mediated gene manipulation, immunostaining, and methylated RNA immunoprecipitation-quantitative PCR were used to explore the underlying mechanisms. We found microglial m6A modification decreased and microglial fat mass and obesity-associated protein (FTO) expression increased in BV2 cells treated with MPP+. Knockdown of FTO expression increased Trim14 expression and protected dopaminergic neurons; Trim14 overexpression significantly blocked the activation of RhoA-ROCK pathway. In MPTP-induced mice, FTO upregulation removes m6A modification from Trim14 mRNA, leading to Trim14 downregulation and subsequent activation of the RhoA-ROCK pathway, thereby exacerbating neuroinflammation. The FTO-Trim14 axis represents a potential therapeutic target for PD.
    Keywords:  FTO; Parkinson's disease; Trim14; m⁶A modification; neuroinflammation
    DOI:  https://doi.org/10.1007/s12035-026-06299-5
  69. Life Sci Alliance. 2027 Jan;pii: e202603860. [Epub ahead of print]10(1):
      GEMIN5 is emerging as a multifunctional RNA-binding protein (RBP) linked to human disease. This RBP comprises a WD40 repeat domain at the N terminus. The C-terminal region (G5C) includes a tetratricopeptide repeat (TPR)-like dimerization module, a non-canonical RNA-binding site (RBS), and an intrinsically disordered region (IDR). Understanding the molecular basis for RNA binding is critical to decipher how GEMIN5 pathological variants impact on their functions. Here we show that the RNA-binding domain consists of an extended binding surface comprising a serine-rich loop and an acidic cluster within the IDR. The RNA binding ability measured in vitro and in soluble cellular extracts indicated that individually, ser-rich motif and acidic cluster mutants diminished RNA binding intensity. However, in the absence of the RBS region, the TPR-extended protein is sufficient to facilitate RNA binding. AlphaFold modeling of the TPR-extended protein shows the assembly of an elongated dimer bound to RNA. The same RBS is observed in the G5C-RNA oligomer model. We propose that the elongated dimer forms an extended binding surface, fine-tuning the RNA binding ability of the G5C architecture.
    DOI:  https://doi.org/10.26508/lsa.202603860
  70. RNA. 2026 Oct 29. pii: rna.081035.126. [Epub ahead of print]
      Trypanosoma cruzi, the causative agent of Chagas disease, regulates gene expression predominantly after transcription because it lacks conventional gene-specific promoters. Cytoplasmic mRNA recapping has been proposed to restore translation-competent mRNAs from silenced transcripts, but its physiological role in kinetoplastids has remained unclear. Here, we show that the cytoplasmic capping enzyme TcCe1 supports transcriptome homeostasis, an effective heat-shock response, and productive intracellular infection of host cells. TcCe1 loss was associated with reduced transcript abundance across extended polycistronic transcription units, impaired induction of proteostasis factors under stress, altered steady-state abundance of uncapped transcripts detected by ligation-mediated RT-qPCR, and marked defects in recovery and infectivity. Because cytoplasmic recapping in kinetoplastids is mechanistically distinct from host pathways, TcCe1 may represent a promising target for parasite-selective therapeutics. Together, our findings highlight the importance of TcCe1 in RNA-level regulation, environmental responsiveness, and host adaptation in this early-branching eukaryote.
    Keywords:  Heat-shock response; Post-transcriptional gene regulation; Trypanosoma; mRNA capping
    DOI:  https://doi.org/10.1261/rna.081035.126
  71. Int J Hematol. 2026 Oct 24.
      Decitabine (DAC) and azacitidine (AZA) are widely recognized as hypomethylating agents for treating myeloid neoplasms; however, recent studies show that their actions extend beyond DNA hypomethylation. DAC acts primarily through incorporation into DNA, forming DNMT1-DNA protein crosslinks (DNMT1-DPCs). Proteolytic processing of these adducts depletes DNMT1 and causes DNA hypomethylation, which can reactivate repressed gene programs, promote myeloid differentiation, and induce innate immune signaling through endogenous retrovirus reactivation. Conversely, the persistence of unresolved DNMT1-DPCs causes replication stress and mitotic perturbation, thereby contributing to direct cytotoxicity. SUMOylation initiates DNMT1-DPC resolution, which involves ubiquitylation by RNF4 and TOPORS, followed by clearance through the proteasome and SPRTN, indicating that the balance between DPC formation and clearance shapes DAC sensitivity. In contrast, AZA exerts prominent RNA-dependent effects in addition to its DNA-mediated effects. Following incorporation into mRNA, AZA induces ribosome stalling and collisions, activating the GCN2-dependent integrated stress response and promoting cytotoxicity. Together with emerging evidence for cell-extrinsic effects, these findings highlight that DAC and AZA are azanucleosides that exert multifaceted effects beyond canonical DNA hypomethylation.
    Keywords:  Acute myeloid leukemia; DNMT1–DNA protein crosslink; Decitabine; azacitidine; Myelodysplastic syndromes
    DOI:  https://doi.org/10.1007/s12185-026-04299-8
  72. bioRxiv. 2026 Oct 07. pii: 2026.10.06.757068. [Epub ahead of print]
      Noncoding RNAs commonly rely on RNA-binding proteins (RBPs) to execute their regulatory functions, but whether RBPs can instead facilitate target recognition by noncoding RNAs is poorly understood. Here, we identify a non-canonical function for Pumilio proteins PUM1 and PUM2 in gene regulation as cofactors of the viral small nuclear RNAs HSUR1 and HSUR2 encoded by Herpesvirus saimiri . HSUR1 and HSUR2 function as microRNA and RBP adaptors that bind target mRNAs to downregulate their expression. We show that HSUR1 and HSUR2 contain conserved Pumilio response elements (PREs) through which they associate with PUM1 and PUM2, without measurably altering PUM protein activity or subcellular distribution in infected cells. Instead, PUM binding is required for HSUR-mediated mRNA repression. Mutation of the PREs abolishes PUM association and HSUR-mediated repression without disrupting HSUR association with microRNAs, whereas tethering PUM1 or PUM2 directly to PRE-deficient HSURs restores repression. Furthermore, HSURs unable to bind PUMs fail to associate with target mRNAs, demonstrating that PUM binding is required for productive HSUR-mRNA engagement. These findings reveal that PUM proteins can function as enabling factors for noncoding RNA target recognition rather than as downstream effectors of repression, expanding the functions of these RBPs in RNA-mediated gene regulation.
    DOI:  https://doi.org/10.64898/2026.10.06.757068
  73. RNA Biol. 2026 Oct 28.
      N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic mRNA, yet its distribution and potential involvement in mRNA 3'-end processing in the malaria parasite Plasmodium falciparum remain poorly understood. Here, we combined nucleotide resolution DART-seq, Nanopore DRS, MeRIP-seq and complementary 3'-end sequencing approaches to investigate the relationship between m6A deposition and mRNA 3'-end formation across the parasite transcriptome. DART-seq identified 2,330 reproducible m6A sites in 1,195 genes, revealing stage-associated differences in the epitranscriptome and preferential enrichment of m6A within 3' UTRs. Independent MeRIP-seq analysis further supported the reproducibility of these methylation patterns. mRNA 3'-end mapping revealed that cleavage and polyadenylation frequently occur within exceptionally adenosine-rich sequence regions. Integration of Nanopore DRS-derived m6A stoichiometry with experimentally defined poly(A) sites revealed preferential m6A enrichment at canonical DRACH motifs approximately 30-50 nucleotides upstream of transcript cleavage sites. Notably, single-molecule DRS analysis demonstrated differential m6A occupancy at shared transcript positions between proximal and distal alternative polyadenylation isoforms of the same gene, with lower occupancy in distal isoforms near proximal cleavage sites. Moreover, m6A enrichment was consistently observed upstream of the utilized poly(A) site in individual transcripts, suggesting an association between m6A deposition and alternative 3'-end formation. Distinct spatial associations of RNA secondary structure and m6A with poly(A) site regions were observed. Together, these findings provide a transcriptome-wide and single-molecule view of m6A modification patterns in relation to native poly(A) sites in P. falciparum, and the data are consistent with a model in which m6A is associated with and may contribute to 3'-end processing.
    Keywords:  DART-seq; Epitranscriptomics; Nanopore RNA sequencing; Plasmodium falciparum; RNA Modification; RNA structure; m6A; polyadenylation
    DOI:  https://doi.org/10.1080/15476286.2026.2753979
  74. Front Cell Dev Biol. 2026 ;14 1943655
      Cancer cell plasticity enables tumor cells to dynamically transition between diverse phenotypic states, including epithelial-mesenchymal plasticity stemness, dormancy, lineage switching, immune evasion, and therapy-resistant phenotypes. Although metabolic reprogramming and epigenetic regulation have each been recognized as hallmarks of cancer, the mechanistic framework linking metabolic adaptation to dynamic cell-state transitions remains incompletely understood. In this Review, we propose that methylation serves as a major mechanistic interface through which metabolic rewiring can influence adaptive cancer cell plasticity. We discuss how one-carbon metabolism regulates the availability of the universal methyl donor S-adenosylmethionine (SAM), thereby influencing DNA methylation, histone methylation, and multiple forms of RNA methylation, with N6-methyladenosine (m6A) representing the principal RNA modification discussed in this review. Rather than responding uniformly to metabolic change, these methylation systems represent distinct but metabolically connected regulatory layers that share dependence on one-carbon metabolism while differing in their biochemical sensitivities and regulatory outputs. Net methylation states, however, are also shaped by metabolically constrained demethylation, including α-ketoglutarate-, oxygen-, Fe2+-, and flavin adenine dinucleotide (FAD)-dependent eraser pathways. Together, these metabolically responsive writing and erasing processes influence transcriptional stability, chromatin accessibility, and post-transcriptional regulation during reversible cell-state transitions. We further examine how environmental and therapeutic stresses, including hypoxia, nutrient limitation, immune surveillance, and anticancer therapy, reshape methylation programs through metabolic adaptation, and how such remodeling may support phenotypic flexibility and survival under selective pressure. Building upon these advances, we propose the concept of the adaptive methylation landscape, a perturbation-responsive, state-associated, and potentially reversible distribution of methylation states that contributes to shaping the spectrum of cellular states accessible during tumor evolution. Finally, we discuss emerging therapeutic strategies targeting the metabolic-methylation axis and highlight how single-cell multi-omics, spatial epigenomics, functional epigenome editing, and AI may enable dynamic mapping of adaptive methylation landscapes. We propose that cancer cell plasticity is not merely a genetic phenomenon but can also be shaped by metabolically responsive methylation programs, providing a testable conceptual framework for future precision epigenetic therapies.
    Keywords:  S-adenosylmethionine; cancer cell plasticity; epigenetic reprogramming; methylation; therapy resistance
    DOI:  https://doi.org/10.3389/fcell.2026.1943655
  75. Int J Mol Sci. 2026 Oct 18. pii: 9245. [Epub ahead of print]27(20):
      Epigenetic dysregulation, particularly N6-methyladenosine (m6A) modification, drives hepatocellular carcinoma (HCC) progression, yet the oncogenic role of the m6A reader IGF2BP3 remains incompletely understood. This study aimed to elucidate the functional contributions and molecular mechanisms of IGF2BP3 in HCC. Multi-omics databases and tissue microarrays were employed to evaluate IGF2BP3 and PLK1 expression, clinicopathological associations, and prognostic value via Kaplan-Meier, Cox regression, and ROC analyses. Molecular interactions were probed by RIP, luciferase reporter, MeRIP, dot blot, and actinomycin D assays. In vitro gain/loss-of-function experiments measured glycolytic metabolites, extracellular acidification rate (ECAR), oxygen consumption rate (OCR), mitochondrial mass/charge, ROS, and key proteins of glycolysis and oxidative phosphorylation (OXPHOS). Both IGF2BP3 and PLK1 were significantly upregulated in HCC versus adjacent non-tumor tissues, correlating positively with advanced clinical stage, higher tumor grade, and poorer overall survival. In the TCGA-LIHC discovery cohort, each showed an independent prognostic association with unfavorable outcomes after adjustment for established clinical covariates. PLK1 mRNA was validated to carry m6A modifications and directly bind IGF2BP3, an interaction abolished by cycloleucine. Functionally, IGF2BP3 upregulated m6A-modified PLK1 by enhancing its mRNA stability, leading to elevated HK2 expression, increased glucose-6-phosphate and lactate levels, and enhanced ECAR, while suppressing mitochondrial respiratory chain complexes, ROS production, and OCR. In conclusion, IGF2BP3 is overexpressed in HCC and tightly associated with aggressive clinicopathological features and adverse outcomes. Altogether, these findings suggest that IGF2BP3 may enhance the stability of the m6A-modified PLK1 transcript, orchestrating a metabolic rewiring from oxidative phosphorylation to glycolysis, revealing a potential IGF2BP3-m6A-PLK1 axis driving HCC aggressiveness and offering potential therapeutic targets for precision intervention.
    Keywords:  IGF2BP3; PLK1; glycolysis; hepatocellular carcinoma; m6A
    DOI:  https://doi.org/10.3390/ijms27209245
  76. Mol Cell. 2026 Oct 26. pii: S1097-2765(26)00706-9. [Epub ahead of print]
      RNA viruses encode multiple layers of information within a single molecule, which functions simultaneously as a template for protein synthesis and as a structured regulatory RNA. These structures control key aspects of viral gene expression, govern host interactions, and mediate immune evasion. Although the prevalence of RNA structure in viral genomes is now well established, only recently have functional and mechanistic studies begun to uncover how these elements act as regulatory modules that shape infection outcomes. With their compact genomes and experimentally tractable life cycles, RNA viruses represent powerful model systems for uncovering the fundamental building blocks of riboregulation and illuminating principles of gene control conserved across eukaryotes. Here, we review current mechanistic understanding of RNA structure-based regulation across diverse viral families and draw parallels to structure-mediated gene control in eukaryotic transcriptomes, highlighting RNA structure as a central regulatory layer in gene expression with broad therapeutic and synthetic biology potential.
    Keywords:  RNA structure; RNA viruses; antiviral therapeutics; eukaryotic gene expression; post-transcriptional regulation; riboregulation; viral gene expression
    DOI:  https://doi.org/10.1016/j.molcel.2026.10.001
  77. Int J Mol Sci. 2026 Oct 20. pii: 9306. [Epub ahead of print]27(20):
      Metabolic reprogramming drives cancer aggressiveness. While hypoxia-inducible factor 1 (HIF1) is commonly associated with glycolysis regulation, the under-investigated HIF2 isoform may also modulate the metabolic profile of breast cancer. We investigated the role of non-canonical HIF2 activation in metabolic adaptation to nutrient availability by culturing MDA-MB-231 and MCF-7 cells under normoxia with varying glucose and glutamine concentrations. Using RNA interference, we downregulated HIF2 and analyzed HIF isoforms and metabolic targets (GLUT1, HK2, PKM2, PDK1) at the transcriptional and protein levels. We observed a new, non-canonical accumulation of HIF2 in MDA-MB-231 cells associated with glucose and glutamine restriction, a phenomenon absent in MCF-7 cells. In MDA-MB-231 cells, silencing HIF2A under standard conditions significantly decreased PDK1 mRNA expression. At the protein level, HIF2 downregulation altered metabolic targets in a context-dependent manner under nutrient restriction. Adding a hypoxia-mimetic (CoCl2) did not fully restore the protein expression patterns, suggesting that HIF2 accumulation may contribute to these context-dependent shifts. HIF2 downregulation decreased glycolytic efficiency under low-glucose conditions. Our findings suggest that HIF2 might modulate the metabolic plasticity of MDA-MB-231 cells through distinct changes in gene expression and post-translational mechanisms. This provides support for investigating the HIF2 isoform while studying breast cancer metabolism and considering it as a potential target for treating triple-negative breast cancer.
    Keywords:  Warburg effect; breast cancer; glycolytic efficiency; hypoxia-inducible factor; metabolic plasticity; metabolism
    DOI:  https://doi.org/10.3390/ijms27209306
  78. Genes (Basel). 2026 Oct 02. pii: 1226. [Epub ahead of print]17(10):
      Reticulocalbin-2 (RCN2), encoded by the human RCN2 gene (HGNC:9935) and historically identified as E6-binding protein, is a CREC-family EF-hand Ca2+-binding protein. Although first characterized as an endoplasmic reticulum (ER)-associated protein, current evidence extends RCN2 biology to splice-variant and localization complexity, protein interactions, regulatory and signaling networks, extracellular activity, cancer, non-malignant disease, and the RCN2-derived hormone Raptin. This review synthesizes the fragmented and methodologically uneven RCN2 literature within an evidence-stratified framework. Mechanistic evidence, including direct biochemical assays and RCN2-directed functional studies, supports selected interaction and signaling relationships, whereas omics, database-derived and single-context observations remain hypothesis-generating. Across disease settings, RCN2 is best interpreted as a context-dependent modulator rather than a uniform oncogenic driver, validated biomarker or established therapeutic target. Translational progress will require molecular-form-specific assays, disease-specific validation and clinically grounded models.
    Keywords:  RCN2; Raptin; calcium homeostasis; cancer; endoplasmic reticulum; protein interactions; signal transduction
    DOI:  https://doi.org/10.3390/genes17101226
  79. Wiley Interdiscip Rev RNA. 2026 Sep-Oct;17(5):pii: e70066. [Epub ahead of print]17(5):
      Transcriptome plasticity is a key driver of proteome diversity, enabling organisms to finely tune gene expression in response to developmental cues and environmental stimuli, essential features for sessile plants facing constant challenges. Among the co-transcriptional processes contributing to this plasticity-such as alternative transcription start sites and alternative splicing-alternative polyadenylation (APA) plays a particularly prominent role, affecting 60%-70% of plant genes. Despite its prevalence, the molecular mechanisms guiding APA and its regulation remain incompletely understood. This review synthesizes recent advances in our understanding of how polyadenylation protein complexes-including Cleavage and Polyadenylation Specificity Factors (CPSF), Cleavage stimulation Factors (CstF), and Cleavage Factors (CF)-interact with cis-regulatory elements to determine poly(A) site choice. We highlight the coordinated actions of these protein families and their dynamic regulation across tissues, developmental stages, and environmental conditions. Furthermore, we propose a conceptual model of the regulatory network involving RNA-protein and protein-protein interactions that govern APA in plants. Deciphering these molecular networks offers promising avenues for targeted manipulation of APA to enhance crop resilience and productivity. Understanding the spatial and temporal regulation of polyadenylation machinery may ultimately enable precision control of gene expression in molecular breeding and agricultural biotechnology.
    Keywords:  alternative polyadenylation; co‐transcriptional regulation; mRNA 3′‐end processing; poly(A) factors
    DOI:  https://doi.org/10.1002/wrna.70066
  80. Med Sci (Basel). 2026 Sep 27. pii: 608. [Epub ahead of print]14(6):
      Dopamine metabolism lies at the intersection of enzymatic catalysis, redox chemistry and cellular compartmentalisation, forming a tightly regulated network that sustains neurotransmission while limiting intrinsic chemical reactivity. In catecholaminergic neurons, dopamine is both an essential signalling molecule and a redox-active substrate prone to oxidation, aldehyde formation and quinone chemistry, requiring coordinated synthesis, storage, degradation and detoxification. Recent advances in structural biology and chemical enzymology have revealed detailed conformational regulation and specific protein interactions among key components of this system-including tyrosine hydroxylase, aromatic L-amino acid decarboxylase, monoamine oxidase and catechol-O-methyltransferase-while suggesting that their spatial organisation may contribute to the control of metabolic flux and exposure to reactive intermediates. Building on previous work on dopamine dyshomeostasis, oxidative stress and reactive metabolites, this Review addresses a less explored integrative question: how structural organisation, catalytic chemistry, intracellular compartmentalisation and redox control collectively influence neuronal resilience. Dopamine metabolism is therefore conceptualised as a chemically constrained and structurally integrated network in which cofactor dynamics, vesicular sequestration, enzyme interactions and redox buffering regulate metabolic flux while limiting reactive intermediates. Disruption of this network-through impaired compartmentalisation, cofactor imbalance, oxidative and nitrosative stress, or neuroinflammatory signalling-can shift dopamine toward electrophilic and oxidative toxicity, contributing to nigrostriatal vulnerability. Neuromelanin formation, reactive nitrogen species signalling and aldehyde accumulation further link dopamine metabolism to mitochondrial dysfunction and immune activation. This framework highlights limitations of therapies centred predominantly on dopamine replacement and supports mechanism-driven approaches aimed at restoring metabolic and redox homeostasis in Parkinson's disease.
    Keywords:  Parkinson’s disease; dopamine metabolism; monoamine oxidase; neuromelanin; redox chemistry; tyrosine hydroxylase
    DOI:  https://doi.org/10.3390/medsci14060608
  81. Yeast. 2026 Oct 28.
      Although most studies in the regulation of gene transcription in eukaryotes have focused on protein-coding genes transcribed into mRNA by RNA polymerase II, the regulation of RNA polymerase I (RNA Pol I) transcription is a key step in the cell's adaptation to environmental or physiological changes. This polymerase transcribes rRNA, a fundamental component of ribosomes that controls the translation of mRNAs into proteins-macromolecules that are both highly abundant and energetically costly to synthesize. Using the yeast Saccharomyces cerevisiae as a model, we have previously shown that adaptation of RNA Pol I synthesis rate (SR) to large changes in cell volume exhibited by some mutants, such as cln3, occurs over the long term through amplification of rDNA gene copies across several hundred cell divisions. However, it remains unclear what happens in the short term in de novo generated mutants that do not display rDNA amplification but exhibit all other phenotypic characteristics of the evolved cln3 mutant. Here, using an in vivo labeling procedure, we show that the RNA Pol I SR is similar in de novo and evolved cln3 mutants and that it seems not to be an alteration in the proportion of active rDNA copies or rRNA processing between both cln3 mutants. Finally, by measuring the ratio of active elongating RNA Pol I molecules to the total loaded onto rDNA genes, we conclude that short-term adaptation occurs through an increase in their transcription efficiency that compensates the decrease in the total number of elongating RNA polymerases.
    Keywords:  RNA polymerase I; Saccharomyces cerevisiae; cell volume; rRNA; synthesis rate; transcription elongation
    DOI:  https://doi.org/10.1002/yea.70053
  82. Pathogens. 2026 Sep 24. pii: 1008. [Epub ahead of print]15(10):
      Staphylococcus epidermidis biofilms are inherently tolerant to antimicrobial treatment, contributing to the persistence and recurrence of biofilm-associated infections. In this study, we examined the phenotypic and proteomic responses of S. epidermidis ATCC 35984 biofilms following exposure to subinhibitory concentrations (1/8× MIC) of levofloxacin, rifampicin, and their combination. Phenotypic analyses revealed clear differences among the treatments. Rifampicin significantly reduced the number of viable biofilm-associated cells, whereas levofloxacin alone had little effect. The combination of rifampicin and levofloxacin produced the most pronounced antibiofilm activity, significantly reducing both biofilm biomass and viability. These findings were supported by confocal laser scanning microscopy, which showed the greatest loss of viable cells and biofilm integrity in the combination-treated biofilms. Label-free quantitative proteomic analysis demonstrated distinct treatment-specific adaptive responses. Rifampicin, either alone or in combination with levofloxacin, triggered broadly increased abundance of proteins involved in translation, energy production, amino acid and nucleotide metabolism, ATP-binding cassette transport, and quorum sensing. In contrast, levofloxacin predominantly suppressed proteins associated with central metabolism, transcription, translation, and biosynthetic pathways. Hierarchical clustering further showed that the proteomic profile of the combination treatment closely resembled that of rifampicin alone, suggesting that rifampicin was the dominant driver of proteomic remodeling. Expression pattern network analysis identified a conserved stress-response signature comprising Fhs, YdaG, PerR, and YcsE across all treatment conditions. Notably, the multidrug efflux pumps NorA and NorC showed decreased protein abundance across all treatment conditions, indicating a potential reduction in efflux-mediated resistance under sub-MIC antibiotic exposure. Taken together, these findings demonstrate that rifampicin retains substantial antibiofilm activity at subinhibitory concentrations and elicits extensive metabolic adaptation, whereas levofloxacin primarily induces a metabolically repressed state. The enhanced activity of the rifampicin-levofloxacin combination appears to arise from complementary effects on biofilm viability and cellular physiology. This study provides new insights into the adaptive responses of S. epidermidis biofilms to sublethal antibiotic stress and highlights the potential of rifampicin-based combination therapies for the management of biofilm-associated infections.
    Keywords:  Staphylococcus epidermidis; biofilm; levofloxacin; proteome; rifampicin
    DOI:  https://doi.org/10.3390/pathogens15101008
  83. Cells. 2026 Oct 15. pii: 1881. [Epub ahead of print]15(20):
      DNA polymerase eta (PolH) is a specialized translesion synthesis DNA polymerase that enables replication across damaged DNA and contributes to cellular tolerance of genotoxic stress. Although PolH has been implicated in chemoresistance, its role in oncogenic signaling remains poorly understood. Here, we identify an unexpected role of PolH in tumor cell growth via mutant p53. We found that overexpression of PolH increases the level of mutant p53 protein. By contrast, knockdown or knockout of PolH inhibits mutant p53 expression by decreasing the half-life of mutant p53 protein. We also found that knockdown or knockout of PolH leads to increased expression of SKP2. As a key E3 ubiquitin ligase component of the SCF complex, we showed that overexpression of SKP2 decreases whereas knockdown of SKP2 increases mutant p53 expression. Moreover, we showed that knockdown of SKP2 abrogates the ability of PolH to regulate mutant p53 expression. To determine the role of SKP2 in mediating mutant p53 proteasome degradation, we showed that SKP2 interacts with mutant p53(R237H). We also found that wild-type but not F-box-deleted SKP2 poly-ubiquitinates mutant p53(R273H). Importantly, we showed that tumor sphere formation is inhibited by knockdown or knockout of PolH, which is further inhibited by knockdown of mutant p53, supporting a cooperative role for PolH and mutant p53 in tumor cell growth. Collectively, these observations indicate that PolH is a previously unrecognized regulator of mutant p53 via SKP2 and that the PolH-mutant p53 pathway can be explored as a therapeutic strategy for mutant p53-driven cancers.
    Keywords:  PolH; SKP2; chemoresistance; mutant p53; protein stability
    DOI:  https://doi.org/10.3390/cells15201881
  84. Neural Regen Res. 2026 Oct 24.
       ABSTRACT: Protein O-GlcNAcylation is a dynamic and reversible post-translational modification that functions as a central nutrient-sensing mechanism linking cellular metabolism to protein function. Controlled by the opposing activities of O-linked β-N-acetylglucosamine transferase and O-GlcNAcase, O-GlcNAcylation regulates thousands of nuclear, cytoplasmic, synaptic, and mitochondrial proteins involved in gene expression, neuronal differentiation, synaptic plasticity, proteostasis, mitochondrial homeostasis, and neuroimmune signaling. The brain exhibits particularly high O-linked β-N-acetylglucosamine activity, reflecting its exceptional metabolic demands and the need to rapidly couple nutrient availability with neuronal function. Emerging evidence demonstrates that precise regulation of O-linked β-N-acetylglucosamine cycling is indispensable throughout the lifespan, from embryonic neurodevelopment to healthy brain aging. Conversely, disruption of O-linked β-N-acetylglucosamine homeostasis caused by genetic defects, metabolic disturbances, or environmental stress contributes to neurodevelopmental disorders. In the aging brain, impaired glucose metabolism and insulin resistance reduce O-GlcNAcylation, promoting mitochondrial dysfunction, neuroinflammation, proteostasis failure, and the accumulation of pathogenic proteins. Consequently, dysregulated O-linked β-N-acetylglucosamine signaling has emerged as a convergent mechanism underlying brain disorders spanning neurodevelopment to neurodegeneration. Although clinical translation remains challenging, growing evidence supports O-GlcNAcylation as a master regulator of brain homeostasis and a promising therapeutic target for neurological disorders. Collectively, this review highlights O-linked β-N-acetylglucosamine signaling as a molecular bridge connecting early brain development, adulthood, and aging, providing an integrated framework for understanding brain physiology and disease.
    Keywords:  O-GlcNAc transferase; O-GlcNAcase; O-GlcNAcylation; brain metabolism; neurodegeneration; neurodevelopment; nutrient sensing; post-translational modification
    DOI:  https://doi.org/10.4103/NRR.NRRONLINE-D-26-00748
  85. Cell Commun Signal. 2026 Jul 29. pii: 576. [Epub ahead of print]24(1):
      Pancreatic β-cells adapt to increased insulin demand through coordinated functional and molecular responses. However, in diabetes, these adaptive pathways eventually fail, driving β-cell dysfunction and demise. One of these pathways is unfolded protein response (UPR), a complex network of sensors and effectors that cooperate to restore endoplasmic reticulum (ER) function under stress. To define the early UPR programs engaged during β-cell adaptation, we employed a murine model of partial β-cell ablation that preserves normoglycemia while imposing an increased secretory workload on the remaining β-cells. Integrating bulk islet transcriptomics with imaging, ultrastructural and physiological analyses, we identified dynamic molecular and functional adaptations during the compensatory phase. The initial transcriptional response was characterised by induction of apoptosis genes and a stress response. This was later replaced by activation of adaptive UPR pathways accompanied by increased insulin processing. Nuclear Atf4 and Xbp1 increased transiently, consistent with engagement of multiple UPR branches through different mechanisms to restore homeostasis. Functionally, partially ablated islets displayed enhanced secretory competence during an acute secondary ER stress challenge, although this adaptive advantage was lost during prolonged stress. Together, these findings define a transient adaptive UPR program that sustains β-cell function during the early response to β-cell loss and provide insight into mechanisms that may be leveraged to enhance β-cell resilience in diabetes.
    Keywords:  ER stress; Insulin; RIP-DTR; Unfolded protein response; β-cells adaptation
    DOI:  https://doi.org/10.1186/s12964-026-03110-9
  86. J Zhejiang Univ Sci B. 2026 Oct 23. pii: 1673-1581(2026)10-1041-18. [Epub ahead of print]27(10): 1041-1058
      The incorporation of non-canonical amino acids (ncAAs) has expanded the chemical diversity and functional repertoire of proteins beyond the 20 canonical amino acids (cAAs). While stop codon suppression introduces a single orthogonal decoding event, sense codon reassignment actively manipulates endogenous translational competition within the ribosomal decoding center. This strategy enables both proteome-wide stochastic labeling and precise site-specific modification of target proteins. In this review, we highlight recent advances in sense codon recoding strategies and their applications in nascent proteome profiling and precision protein engineering. We first discuss global metabolic labeling using endogenous aminoacyl-transfer RNA (tRNA) synthetases and the programmable stochastic orthogonal recoding of translation (SORT) platform. We then examine site-specific approaches, including competitive rare codon recoding (RCR) in mammalian cells, genome-scale codon compression in Escherichia coli, and the creation of blank coding channels through total genome synthesis. These complementary paradigms have enabled high-resolution spatiotemporal mapping of nascent proteomes in live animals, multiplexed incorporation of up to five distinct ncAAs in a single mammalian protein, and the in vivobiosynthesis of complex sequence-defined polymers. By converting translational competition into an engineerable parameter, sense codon reassignment offers new opportunities to transform our ability to decode complex biological networks and develop next-generation molecular medicines.
    Keywords:  Genetic code expansion (GCE); Orthogonal translation system (OTS); Rare codon; Sense codon reassignment; Stochastic orthogonal recoding of translation (SORT)
    DOI:  https://doi.org/10.1631/jzus.B2600331